{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T22:58:52Z","timestamp":1793228332831,"version":"4.5.0"},"reference-count":265,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T00:00:00Z","timestamp":1772841600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000},"content-version":"vor","delay-in-days":39,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100005047","name":"Natural Science Foundation of Liaoning Province","doi-asserted-by":"publisher","award":["2025JH2\/101800397"],"award-info":[{"award-number":["2025JH2\/101800397"]}],"id":[{"id":"10.13039\/501100005047","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-026-04243-2","type":"journal-article","created":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T13:24:50Z","timestamp":1772889890000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Multifunctional nanoplatforms deciphering immune resistance in bone tumors: cooperative delivery, immune reprogramming and microenvironment remodeling"],"prefix":"10.1186","volume":"24","author":[{"given":"Jiahang","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shenglong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,7]]},"reference":[{"key":"4243_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-025-13720-0","volume":"25","author":"H Hosseini","year":"2025","unstructured":"Hosseini H, Heydari S, Hushmandi K, Daneshi S, Raesi R. Bone tumors: a systematic review of prevalence, risk determinants, and survival patterns. BMC Cancer. 2025;25:321.","journal-title":"BMC Cancer"},{"key":"4243_CR2","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1097\/CM9.0000000000002547","volume":"136","author":"Y Xi","year":"2023","unstructured":"Xi Y, Qiao L, Na B, Liu H, Zhang S, Zheng R, Wang W, Sun K, Wei W, He J. Primary malignant bone tumors incidence, mortality, and trends in China from 2000 to 2015. Chin Med J (Engl). 2023;136:2037\u201343.","journal-title":"Chin Med J (Engl)"},{"key":"4243_CR3","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1001\/jamaoncol.2020.0197","volume":"6","author":"L Mirabello","year":"2020","unstructured":"Mirabello L, Zhu B, Koster R, Karlins E, Dean M, Yeager M, et al. Frequency of pathogenic germline variants in cancer-susceptibility genes in patients with osteosarcoma. JAMA Oncol. 2020;6:724\u201334.","journal-title":"JAMA Oncol"},{"key":"4243_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-99605-5","volume":"15","author":"Y Pan","year":"2025","unstructured":"Pan Y, Tang B, Guo Y, Cai Y, Li YY. Global burden of non-melanoma skin cancers among older adults: a comprehensive analysis using machine learning approaches. Sci Rep. 2025;15:15266.","journal-title":"Sci Rep"},{"key":"4243_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15102804","author":"AA Kruiswijk","year":"2023","unstructured":"Kruiswijk AA, Dorleijn DMJ, van de Marang- Mheen PJ, van de Sande MAJ, van Bodegom-Vos L. Health-related quality of life of bone and soft-tissue tumor patients around the time of diagnosis. Cancers (Basel). 2023;15:2804. https:\/\/doi.org\/10.3390\/cancers15102804.","journal-title":"Cancers (Basel)"},{"key":"4243_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11072062","author":"D Guadagnolo","year":"2023","unstructured":"Guadagnolo D, Mastromoro G, Marchionni E, Germani A, Libi F, Sadeghi S, et al. Heterozygous pathogenic nonsense variant in the ATM gene in a family with unusually high gastric cancer susceptibility. Biomedicines. 2023;11:2062.  https:\/\/doi.org\/10.3390\/biomedicines11072062.","journal-title":"Biomedicines"},{"key":"4243_CR7","doi-asserted-by":"publisher","DOI":"10.1080\/15384047.2024.2345977","volume":"25","author":"Y Liu","year":"2024","unstructured":"Liu Y, Qi L, Ye B, Wang A, Lu J, Qu L, et al. MOICS, a novel classier deciphering immune heterogeneity and aid precise management of clear cell renal cell carcinoma at multiomics level. Cancer Biol Ther. 2024;25:2345977.","journal-title":"Cancer Biol Ther"},{"key":"4243_CR8","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1001\/jamaoncol.2021.6628","volume":"8","author":"I Surgery","year":"2022","unstructured":"Prophylactic Antibiotic Regimens in Tumor, Surgery I, Ghert M, Schneider P, Guyatt G, Thabane L, Velez R, O\u2019Shea T, Randall RL, Turcotte R, Wilson D, et al. Comparison of Prophylactic Intravenous Antibiotic Regimens After Endoprosthetic Reconstruction for Lower Extremity Bone Tumors: A Randomized Clinical Trial. JAMA Oncol. 2022;8:345\u201353.","journal-title":"JAMA Oncol"},{"key":"4243_CR9","doi-asserted-by":"publisher","first-page":"13593","DOI":"10.2147\/IJN.S493185","volume":"19","author":"D Zhang","year":"2024","unstructured":"Zhang D, Zhang M, Fan H, Sun R, Liu J, Ma W. FA-PEG modified ZIF(Mn) nanoparticles loaded with baicalin for imaging-guided treatment of melanoma in mice. Int J Nanomed. 2024;19:13593\u2013613.","journal-title":"Int J Nanomed"},{"key":"4243_CR10","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1001\/jamaoncol.2020.7857","volume":"7","author":"A Ali","year":"2021","unstructured":"Ali A, Hoyle A, Haran AM, Brawley CD, Cook A, Amos C, et al. Association of bone metastatic burden with survival benefit from prostate radiotherapy in patients with newly diagnosed metastatic prostate cancer: a secondary analysis of a randomized clinical trial. JAMA Oncol. 2021;7:555\u201363.","journal-title":"JAMA Oncol"},{"key":"4243_CR11","doi-asserted-by":"publisher","first-page":"3192","DOI":"10.1200\/JCO.19.00915","volume":"37","author":"U Dirksen","year":"2019","unstructured":"Dirksen U, Brennan B, Le Deley MC, Cozic N, van den Berg H, Bhadri V, et al. High-dose chemotherapy compared with standard chemotherapy and lung radiation in Ewing sarcoma with pulmonary metastases: results of the European Ewing Tumour Working Initiative of National Groups, 99 Trial and EWING 2008. J Clin Oncol. 2019;37:3192\u2013202.","journal-title":"J Clin Oncol"},{"key":"4243_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16213565","author":"KH Smith","year":"2024","unstructured":"Smith KH, Trovillion EM, Sholler C, Gandra D, McKinney KQ, Mulama D, et al. Panobinostat synergizes with chemotherapeutic agents and improves efficacy of standard-of-care chemotherapy combinations in Ewing sarcoma cells. Cancers (Basel). 2024;16:3565. https:\/\/doi.org\/10.3390\/cancers16213565","journal-title":"Cancers (Basel)"},{"key":"4243_CR13","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s11136-024-03831-9","volume":"34","author":"EM Knight","year":"2025","unstructured":"Knight EM, Carluzzo KL, Reeve BB, Mueller KL, Singh JA, Lin L, Schifferdecker KE. Health-related quality of life profiles of adults with arthritis and\/or fibromyalgia: a cross-sectional study. Qual Life Res. 2025;34:523\u201334.","journal-title":"Qual Life Res"},{"key":"4243_CR14","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2015433118","author":"JS Song","year":"2021","unstructured":"Song JS, Chang CC, Wu CH, Dinh TK, Jan JJ, Huang KW, et al. A highly selective and potent CXCR4 antagonist for hepatocellular carcinoma treatment. Proc Natl Acad Sci U S A. 2021;118:e2015433118. https:\/\/doi.org\/10.1073\/pnas.2015433118.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4243_CR15","first-page":"10","volume":"75","author":"RL Siegel","year":"2025","unstructured":"Siegel RL, Kratzer TB, Giaquinto AN, Sung H, Jemal A. Cancer statistics, 2025. CA Cancer J Clin. 2025;75:10\u201345.","journal-title":"CA Cancer J Clin"},{"key":"4243_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2024.103460","volume":"79","author":"Q Zou","year":"2025","unstructured":"Zou Q, Zhou X, Lai J, Zhou H, Su J, Zhang Z, et al. Targeting p62 by sulforaphane promotes autolysosomal degradation of SLC7A11, inducing ferroptosis for osteosarcoma treatment. Redox Biol. 2025;79:103460.","journal-title":"Redox Biol"},{"key":"4243_CR17","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1002\/1878-0261.12189","volume":"12","author":"L Pietrovito","year":"2018","unstructured":"Pietrovito L, Leo A, Gori V, Lulli M, Parri M, Becherucci V, Piccini L, Bambi F, Taddei ML, Chiarugi P. Bone marrow-derived mesenchymal stem cells promote invasiveness and transendothelial migration of osteosarcoma cells via a mesenchymal to amoeboid transition. Mol Oncol. 2018;12:659\u201376.","journal-title":"Mol Oncol"},{"key":"4243_CR18","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1016\/j.annonc.2021.08.1995","volume":"32","author":"SJ Strauss","year":"2021","unstructured":"Strauss SJ, Frezza AM, Abecassis N, Bajpai J, Bauer S, Biagini R, et al. Bone sarcomas: ESMO-EURACAN-GENTURIS-ERN PaedCan clinical practice guideline for diagnosis, treatment and follow-up. Ann Oncol. 2021;32:1520\u201336.","journal-title":"Ann Oncol"},{"key":"4243_CR19","doi-asserted-by":"publisher","first-page":"3603","DOI":"10.1172\/JCI133334","volume":"130","author":"K Wang","year":"2020","unstructured":"Wang K, Gu Y, Liao Y, Bang S, Donnelly CR, Chen O, Tao X, Mirando AJ, Hilton MJ, Ji RR. PD-1 blockade inhibits osteoclast formation and murine bone cancer pain. J Clin Invest. 2020;130:3603\u201320.","journal-title":"J Clin Invest"},{"key":"4243_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-20059-6","volume":"11","author":"Y Zhou","year":"2020","unstructured":"Zhou Y, Yang D, Yang Q, Lv X, Huang W, Zhou Z, et al. Single-cell RNA landscape of intratumoral heterogeneity and immunosuppressive microenvironment in advanced osteosarcoma. Nat Commun. 2020;11:6322.","journal-title":"Nat Commun"},{"key":"4243_CR21","doi-asserted-by":"publisher","first-page":"217302","DOI":"10.1016\/j.canlet.2024.217302","volume":"606","author":"N Nerlakanti","year":"2024","unstructured":"Nerlakanti N, McGuire JJ, Bishop RT, Nasr MM, Li T, Reed DR, Lynch CC. Histone deacetylase upregulation of neuropilin-1 in osteosarcoma is essential for pulmonary metastasis. Cancer Lett. 2024;606:217302.","journal-title":"Cancer Lett"},{"key":"4243_CR22","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1158\/2159-8290.CD-17-1152","volume":"9","author":"LC Sayles","year":"2019","unstructured":"Sayles LC, Breese MR, Koehne AL, Leung SG, Lee AG, Liu HY, et al. Genome-informed targeted therapy for osteosarcoma. Cancer Discov. 2019;9:46\u201363.","journal-title":"Cancer Discov"},{"key":"4243_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-023-11144-2","volume":"23","author":"A Yokoi","year":"2023","unstructured":"Yokoi A, Nakamura Y, Hashimura M, Oguri Y, Matsumoto T, Nakagawa M, et al. Anaplastic lymphoma kinase overexpression enhances aggressive phenotypic characteristics of endometrial carcinoma. BMC Cancer. 2023;23:765.","journal-title":"BMC Cancer"},{"key":"4243_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-57527-8","volume":"14","author":"TD Patel","year":"2024","unstructured":"Patel TD, Grimm SL, Kanchi RS, Gandhi T, Koirala A, Yustein JT, et al. Identification of an early survival prognostic gene signature for localized osteosarcoma patients. Sci Rep. 2024;14:7327.","journal-title":"Sci Rep"},{"key":"4243_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1392667","volume":"14","author":"BJ Knapp","year":"2024","unstructured":"Knapp BJ, Cittolin-Santos GF, Flanagan ME, Grandhi N, Gao F, Samson PP, et al. Incidence and risk factors for bone metastases at presentation in solid tumors. Front Oncol. 2024;14:1392667.","journal-title":"Front Oncol"},{"key":"4243_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-023-11390-4","volume":"23","author":"L Xie","year":"2023","unstructured":"Xie L, Liang X, Xu J, Sun X, Liu K, Sun K, et al. Exploratory study of an anti-PD-L1\/TGF-beta antibody, TQB2858, in patients with refractory or recurrent osteosarcoma and alveolar soft part sarcoma: a report from Chinese sarcoma study group (TQB2858-Ib-02). BMC Cancer. 2023;23:868.","journal-title":"BMC Cancer"},{"key":"4243_CR27","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1007\/s00330-024-11060-4","volume":"35","author":"C Nelles","year":"2025","unstructured":"Nelles C, Graf M, Bernard P, Persigehl T, Grosse Hokamp N, Zopfs D, Maintz D, Kreuzberg N, Wolf J, Brockelmann PJ, Lennartz S. Real-world response assessment of immune checkpoint inhibition: comparing iRECIST and RECIST 1.1 in melanoma and non-small cell lung cancer patients. Eur Radiol. 2025;35:2084\u201393.","journal-title":"Eur Radiol"},{"key":"4243_CR28","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1021\/acsbiomaterials.1c00081","volume":"7","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Yuan T, Li Z, Luo C, Wu Y, Zhang J, et al. Hyaluronate-based self-stabilized nanoparticles for immunosuppression reversion and immunochemotherapy in osteosarcoma treatment. ACS Biomater Sci Eng. 2021;7:1515\u201325.","journal-title":"ACS Biomater Sci Eng"},{"key":"4243_CR29","doi-asserted-by":"publisher","first-page":"4968","DOI":"10.1158\/1078-0432.CCR-22-1471","volume":"28","author":"AR Cillo","year":"2022","unstructured":"Cillo AR, Mukherjee E, Bailey NG, Onkar S, Daley J, Salgado C, et al. Ewing sarcoma and osteosarcoma have distinct immune signatures and intercellular communication networks. Clin Cancer Res. 2022;28:4968\u201382.","journal-title":"Clin Cancer Res"},{"key":"4243_CR30","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2021.2024941","volume":"11","author":"J Lin","year":"2022","unstructured":"Lin J, Xu A, Jin J, Zhang M, Lou J, Qian C, et al. MerTK-mediated efferocytosis promotes immune tolerance and tumor progression in osteosarcoma through enhancing M2 polarization and PD-L1 expression. Oncoimmunology. 2022;11:2024941.","journal-title":"Oncoimmunology"},{"key":"4243_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8030385","author":"KW Huang","year":"2019","unstructured":"Huang KW, Jayant K, Lee PH, Yang PC, Hsiao CY, Habib N, et al. Positive immuno-modulation following radiofrequency assisted liver resection in hepatocellular carcinoma. J Clin Med. 2019;8:385. https:\/\/doi.org\/10.3390\/jcm8030385.","journal-title":"J Clin Med"},{"key":"4243_CR32","doi-asserted-by":"publisher","first-page":"e36016","DOI":"10.1016\/j.heliyon.2024.e36016","volume":"10","author":"T Hu","year":"2024","unstructured":"Hu T, Sun W, Jin Y, Dong Y, Liu W, Sun Z, Xiang Y, Chen Y. The combination of apatinib and antigen-specific DC-induced T cells exert antitumor effects by potently improving the immune microenvironment of osteosarcoma. Heliyon. 2024;10:e36016.","journal-title":"Heliyon"},{"key":"4243_CR33","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2024-009221","author":"JA Lake","year":"2024","unstructured":"Lake JA, Woods E, Hoffmeyer E, Schaller KL, Cruz-Cruz J, Fernandez J, et al. Directing B7-H3 chimeric antigen receptor T cell homing through IL-8 induces potent antitumor activity against pediatric sarcoma. J Immunother Cancer. 2024;12:e009221. https:\/\/doi.org\/10.1136\/jitc-2024-009221.","journal-title":"J Immunother Cancer"},{"key":"4243_CR34","doi-asserted-by":"publisher","first-page":"4434","DOI":"10.1158\/1078-0432.CCR-23-3298","volume":"30","author":"LJ Talbot","year":"2024","unstructured":"Talbot LJ, Chabot A, Ross AB, Beckett A, Nguyen P, Fleming A, et al. Redirecting B7-H3.CAR T cells to chemokines expressed in osteosarcoma enhances homing and antitumor activity in preclinical models. Clin Cancer Res. 2024;30:4434\u201349.","journal-title":"Clin Cancer Res"},{"key":"4243_CR35","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-001772","author":"JA Ligon","year":"2021","unstructured":"Ligon JA, Choi W, Cojocaru G, Fu W, Hsiue EH, Oke TF, et al. Pathways of immune exclusion in metastatic osteosarcoma are associated with inferior patient outcomes. J Immunother Cancer. 2021;9:e001772. https:\/\/doi.org\/10.1136\/jitc-2020-001772.","journal-title":"J Immunother Cancer"},{"key":"4243_CR36","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1021\/acsnano.2c07295","volume":"17","author":"L Xu","year":"2023","unstructured":"Xu L, Xu M, Sun X, Feliu N, Feng L, Parak WJ, et al. Quantitative comparison of gold nanoparticle delivery via the enhanced permeation and retention (EPR) effect and mesenchymal stem cell (MSC)-based targeting. ACS Nano. 2023;17:2039\u201352.","journal-title":"ACS Nano"},{"key":"4243_CR37","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1038\/s41565-023-01374-7","volume":"18","author":"Z Luo","year":"2023","unstructured":"Luo Z, Lu Y, Shi Y, Jiang M, Shan X, Li X, et al. Neutrophil hitchhiking for drug delivery to the bone marrow. Nat Nanotechnol. 2023;18:647\u201356.","journal-title":"Nat Nanotechnol"},{"key":"4243_CR38","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.biomaterials.2018.08.033","volume":"183","author":"Y Wang","year":"2018","unstructured":"Wang Y, Huang Q, He X, Chen H, Zou Y, Li Y, Lin K, Cai X, Xiao J, Zhang Q, Cheng Y. Multifunctional melanin-like nanoparticles for bone-targeted chemo-photothermal therapy of malignant bone tumors and osteolysis. Biomaterials. 2018;183:10\u20139.","journal-title":"Biomaterials"},{"key":"4243_CR39","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1080\/10837450.2020.1798458","volume":"25","author":"S Kamble","year":"2020","unstructured":"Kamble S, Varamini P, Mullner M, Pelras T, Rohanizadeh R. Bisphosphonate-functionalized micelles for targeted delivery of curcumin to metastatic bone cancer. Pharm Dev Technol. 2020;25:1118\u201326.","journal-title":"Pharm Dev Technol"},{"key":"4243_CR40","first-page":"333","volume":"7","author":"Y Yan","year":"2022","unstructured":"Yan Y, Zhou L, Sun Z, Song D, Cheng Y. Targeted and intracellular delivery of protein therapeutics by a boronated polymer for the treatment of bone tumors. Bioact Mater. 2022;7:333\u201340.","journal-title":"Bioact Mater"},{"key":"4243_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2020.120574","volume":"268","author":"M Shu","year":"2021","unstructured":"Shu M, Tang J, Chen L, Zeng Q, Li C, Xiao S, et al. Tumor microenvironment triple-responsive nanoparticles enable enhanced tumor penetration and synergetic chemo-photodynamic therapy. Biomaterials. 2021;268:120574.","journal-title":"Biomaterials"},{"key":"4243_CR42","doi-asserted-by":"publisher","first-page":"2933","DOI":"10.1021\/acs.accounts.3c00394","volume":"56","author":"S Zhou","year":"2023","unstructured":"Zhou S, Cheng F, Zhang Y, Su T, Zhu G. Engineering and delivery of cGAS-STING immunomodulators for the immunotherapy of cancer and autoimmune diseases. Acc Chem Res. 2023;56:2933\u201343.","journal-title":"Acc Chem Res"},{"key":"4243_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17637-z","volume":"11","author":"X Li","year":"2020","unstructured":"Li X, Wang X, Ito A, Tsuji NM. A nanoscale metal organic frameworks-based vaccine synergises with PD-1 blockade to potentiate anti-tumour immunity. Nat Commun. 2020;11:3858.","journal-title":"Nat Commun"},{"key":"4243_CR44","doi-asserted-by":"publisher","first-page":"25400","DOI":"10.1021\/acsanm.4c04294","volume":"7","author":"L He","year":"2024","unstructured":"He L, Javid Anbardan Z, Habibovic P, van Rijt S. Doxorubicin- and Selenium-Incorporated Mesoporous Silica Nanoparticles as a Combination Therapy for Osteosarcoma. ACS Appl Nano Mater. 2024;7:25400\u201311.","journal-title":"ACS Appl Nano Mater"},{"key":"4243_CR45","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1038\/s41551-021-00712-1","volume":"5","author":"Q Hu","year":"2021","unstructured":"Hu Q, Li H, Archibong E, Chen Q, Ruan H, Ahn S, Dukhovlinova E, Kang Y, Wen D, Dotti G, Gu Z. Inhibition of post-surgery tumour recurrence via a hydrogel releasing CAR-T cells and anti-PDL1-conjugated platelets. Nat Biomed Eng. 2021;5:1038\u201347.","journal-title":"Nat Biomed Eng"},{"key":"4243_CR46","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202402678","volume":"11","author":"Z Liu","year":"2024","unstructured":"Liu Z, Li S, Xiao Y, Liu X, Zhang B, Zeng Q, et al. A multi-functional nanoadjuvant coupling manganese with toll-like 9 agonist stimulates potent innate and adaptive anti-tumor immunity. Adv Sci Weinh. 2024;11:e2402678.","journal-title":"Adv Sci Weinh"},{"key":"4243_CR47","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.actbio.2024.12.060","volume":"193","author":"Y Zhao","year":"2025","unstructured":"Zhao Y, Zhao X, Wang X, Ma Z, Yan J, Li S, Wang N, Jiao J, Cui J, Zhang G. Polyphenol-mediated assembly of toll-like receptor 7\/8 agonist nanoparticles for effective tumor immunotherapy. Acta Biomater. 2025;193:417\u201328.","journal-title":"Acta Biomater"},{"key":"4243_CR48","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202402966","volume":"14","author":"B Marwedel","year":"2025","unstructured":"Marwedel B, De May H, Anderson L, Medina LY, Kennedy E, Flores E, et al. TLR agonist nano immune therapy clears peritoneal and systemic ovarian cancer. Adv Healthc Mater. 2025;14:e2402966.","journal-title":"Adv Healthc Mater"},{"key":"4243_CR49","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1021\/acs.molpharmaceut.2c00737","volume":"20","author":"G Jones","year":"2023","unstructured":"Jones G, Zeng L, Kim J. Mechanism-based pharmacokinetic modeling of absorption and disposition of a deferoxamine-based nanochelator in rats. Mol Pharm. 2023;20:481\u201390.","journal-title":"Mol Pharm"},{"key":"4243_CR50","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202500592","volume":"14","author":"GS Dasanayake","year":"2025","unstructured":"Dasanayake GS, Hamadani CM, Hailu F, Owolabi I, Patel M, Chism CM, et al. Glyco ionic liquids as novel nanoparticle coatings to enhance triple-negative breast cancer drug delivery. Adv Healthc Mater. 2025;14:e2500592.","journal-title":"Adv Healthc Mater"},{"key":"4243_CR51","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15061603","author":"LE Swart","year":"2023","unstructured":"Swart LE, Fens M, van Oort A, Waranecki P, Mata Casimiro LD, Tuk D, et al. Increased bone marrow uptake and accumulation of very-late antigen-4 targeted lipid nanoparticles. Pharmaceutics. 2023;15:1603. https:\/\/doi.org\/10.3390\/pharmaceutics15061603.","journal-title":"Pharmaceutics"},{"key":"4243_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-40015-4","volume":"14","author":"MI Setyawati","year":"2023","unstructured":"Setyawati MI, Wang Q, Ni N, Tee JK, Ariga K, Ke PC, et al. Engineering tumoral vascular leakiness with gold nanoparticles. Nat Commun. 2023;14:4269.","journal-title":"Nat Commun"},{"key":"4243_CR53","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1055\/a-1486-3683","volume":"60","author":"H Ranjbar","year":"2021","unstructured":"Ranjbar H, Pourhabib Z. Human absorbed dose evaluation of [177Lu]Lu-IBA as a bone palliative candidate. Nuklearmedizin. 2021;60:375\u201380.","journal-title":"Nuklearmedizin"},{"key":"4243_CR54","doi-asserted-by":"publisher","first-page":"10090","DOI":"10.1021\/acsnano.2c12685","volume":"17","author":"L Xu","year":"2023","unstructured":"Xu L, Deng H, Wu L, Wang D, Shi L, Qian Q, et al. Supramolecular cyclic dinucleotide nanoparticles for STING-mediated cancer immunotherapy. ACS Nano. 2023;17:10090\u2013103.","journal-title":"ACS Nano"},{"key":"4243_CR55","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1186\/s12967-025-06920-6","volume":"23","author":"C Dai","year":"2025","unstructured":"Dai C, Shen B, Liu S, Li C, Yang S, Wang J, Zhang J, Liu M, Zhu Z, Shi W, et al. Pharmacologic inhibition of CSF-1R suppresses intrinsic tumor cell growth in osteosarcoma with CSF-1R overexpression. J Transl Med. 2025;23:900.","journal-title":"J Transl Med"},{"key":"4243_CR56","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1038\/s41423-023-01093-y","volume":"20","author":"J Yu","year":"2023","unstructured":"Yu J, Cui J, Zhang X, Xu H, Chen Z, Li Y, et al. The OX40-TRAF6 axis promotes CTLA-4 degradation to augment antitumor CD8(+) T-cell immunity. Cell Mol Immunol. 2023;20:1445\u201356.","journal-title":"Cell Mol Immunol"},{"key":"4243_CR57","first-page":"221","volume":"17","author":"L Fu","year":"2022","unstructured":"Fu L, Zhang W, Zhou X, Fu J, He C. Tumor cell membrane-camouflaged responsive nanoparticles enable MRI-guided immuno-chemodynamic therapy of orthotopic osteosarcoma. Bioact Mater. 2022;17:221\u201333.","journal-title":"Bioact Mater"},{"key":"4243_CR58","doi-asserted-by":"publisher","first-page":"2384","DOI":"10.1016\/j.apsb.2020.06.006","volume":"10","author":"Y Huang","year":"2020","unstructured":"Huang Y, Xiao Z, Guan Z, Zeng Z, Shen Y, Xu X, Zhao C. Bone-seeking nanoplatform co-delivering cisplatin and zoledronate for synergistic therapy of breast cancer bone metastasis and bone resorption. Acta Pharm Sin B. 2020;10:2384\u2013403.","journal-title":"Acta Pharm Sin B"},{"key":"4243_CR59","doi-asserted-by":"publisher","first-page":"7742","DOI":"10.1039\/D1RA08061J","volume":"12","author":"J Zhou","year":"2022","unstructured":"Zhou J, Meli VS, Yu-Tin Chen E, Kapre R, Nagalla R, Xiao W, Borowsky AD, Lam KS, Liu WF, Louie AY. Magnetic resonance imaging of tumor-associated-macrophages (TAMs) with a nanoparticle contrast agent. RSC Adv. 2022;12:7742\u201356.","journal-title":"RSC Adv"},{"key":"4243_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.tice.2025.102836","volume":"95","author":"Z Cheng","year":"2025","unstructured":"Cheng Z, Liu D, Park JY, Meng X, Yang Y, Dang M, et al. Evaluation of the management of rotator cuff injuries utilising superparamagnetic iron oxide tracking stem cells. Tissue Cell. 2025;95:102836.","journal-title":"Tissue Cell"},{"key":"4243_CR61","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-59065-x","volume":"16","author":"X Wang","year":"2025","unstructured":"Wang X, Norgate E, Dai J, Benoit F, Bristow T, England RM, et al. Conformational landscapes of rigid and flexible molecules explored with variable temperature ion mobility-mass spectrometry. Nat Commun. 2025;16:4183.","journal-title":"Nat Commun"},{"key":"4243_CR62","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202412626","volume":"12","author":"C Xu","year":"2025","unstructured":"Xu C, Liu M, Xie X, Li Z, Zhu Y, Ye Y, et al. Multifunctional boron-based 2D nanoplatforms ameliorate severe respiratory inflammation by targeting multiple inflammatory mediators. Adv Sci (Weinh). 2025;12:e2412626.","journal-title":"Adv Sci (Weinh)"},{"key":"4243_CR63","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202407609","volume":"12","author":"X Li","year":"2025","unstructured":"Li X, He G, Jin H, Xiang X, Li D, Peng R, et al. Ultrasound-activated precise sono-immunotherapy for breast cancer with reduced pulmonary fibrosis. Adv Sci. 2025;12:e2407609.","journal-title":"Adv Sci"},{"key":"4243_CR64","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-024-01641-7","volume":"17","author":"M Pezzella","year":"2024","unstructured":"Pezzella M, Quintarelli C, Quadraccia MC, Sarcinelli A, Manni S, Iaffaldano L, et al. Tumor-derived G-CSF induces an immunosuppressive microenvironment in an osteosarcoma model, reducing response to CAR.GD2 T-cells. J Hematol Oncol. 2024;17:127.","journal-title":"J Hematol Oncol"},{"key":"4243_CR65","doi-asserted-by":"publisher","DOI":"10.1186\/s12929-023-00917-3","volume":"30","author":"C Wu","year":"2023","unstructured":"Wu C, Gong S, Duan Y, Deng C, Kallendrusch S, Berninghausen L, et al. A tumor microenvironment-based prognostic index for osteosarcoma. J Biomed Sci. 2023;30:23.","journal-title":"J Biomed Sci"},{"key":"4243_CR66","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1158\/1535-7163.MCT-20-0591","volume":"20","author":"T Fujiwara","year":"2021","unstructured":"Fujiwara T, Yakoub MA, Chandler A, Christ AB, Yang G, Ouerfelli O, et al. CSF1\/CSF1R signaling inhibitor Pexidartinib (PLX3397) reprograms tumor-associated macrophages and stimulates T-cell infiltration in the sarcoma microenvironment. Mol Cancer Ther. 2021;20:1388\u201399.","journal-title":"Mol Cancer Ther"},{"key":"4243_CR67","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1021\/acs.molpharmaceut.2c00605","volume":"20","author":"T Huang","year":"2023","unstructured":"Huang T, Wu J, Mu J, Gao J. Advanced therapies for traumatic central nervous system injury: delivery strategy reinforced efficient microglial manipulation. Mol Pharm. 2023;20:41\u201356.","journal-title":"Mol Pharm"},{"key":"4243_CR68","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.arcmed.2020.10.018","volume":"52","author":"Z Cheng","year":"2021","unstructured":"Cheng Z, Wang L, Wu C, Huang L, Ruan Y, Xue W. Tumor-derived exosomes induced M2 macrophage polarization and promoted the metastasis of osteosarcoma cells through Tim-3. Arch Med Res. 2021;52:200\u201310.","journal-title":"Arch Med Res"},{"key":"4243_CR69","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.110869","volume":"124","author":"S Feng","year":"2023","unstructured":"Feng S, Zhao J, Yang T, Li L. TMPRSS11D\/ALR-mediated ER stress regulates the function of myeloid-derived suppressor cells in the cervical cancer microenvironment. Int Immunopharmacol. 2023;124:110869.","journal-title":"Int Immunopharmacol"},{"key":"4243_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.108964","volume":"110","author":"B Li","year":"2022","unstructured":"Li B, Luo Y, Zhou Y, Wu J, Fang Z, Li Y. Role of sanguinarine in regulating immunosuppression in a Lewis lung cancer mouse model. Int Immunopharmacol. 2022;110:108964.","journal-title":"Int Immunopharmacol"},{"key":"4243_CR71","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202416501","volume":"12","author":"JY Cheng","year":"2025","unstructured":"Cheng JY, Tsai HH, Hung JT, Hung TH, Lin CC, Lee CW, et al. Tumor-associated glycan exploits adenosine receptor 2A signaling to facilitate immune evasion. Adv Sci Weinh. 2025;12:e2416501.","journal-title":"Adv Sci Weinh"},{"key":"4243_CR72","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.jconrel.2022.01.051","volume":"343","author":"J Du","year":"2022","unstructured":"Du J, Wang C, Chen Y, Zhong L, Liu X, Xue L, et al. Targeted downregulation of HIF-1alpha for restraining circulating tumor microemboli mediated metastasis. J Control Release. 2022;343:457\u201368.","journal-title":"J Control Release"},{"key":"4243_CR73","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202103497","volume":"33","author":"Y Wang","year":"2021","unstructured":"Wang Y, Yu J, Luo Z, Shi Q, Liu G, Wu F, et al. Engineering endogenous tumor-associated macrophage-targeted biomimetic nano-RBC to reprogram tumor immunosuppressive microenvironment for enhanced chemo-immunotherapy. Adv Mater. 2021;33:e2103497.","journal-title":"Adv Mater"},{"key":"4243_CR74","doi-asserted-by":"crossref","unstructured":"Erickson HL, Taniguchi S, Raman A, Leitenberger JJ, Malhotra SV, Oshimori N. Cancer stem cells release interleukin-33 within large oncosomes to promote immunosuppressive differentiation of macrophage precursors. Immunity 2024, 57:1908\u20131922 e1906.","DOI":"10.1016\/j.immuni.2024.07.004"},{"key":"4243_CR75","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1097\/CM9.0000000000001558","volume":"135","author":"X Zhuang","year":"2021","unstructured":"Zhuang X, Shi G, Hu X, Wang H, Sun W, Wu Y. Interferon-gamma inhibits aldehyde dehydrogenasebright cancer stem cells in the 4T1 mouse model of breast cancer. Chin Med J (Engl). 2021;135:194\u2013204.","journal-title":"Chin Med J (Engl)"},{"key":"4243_CR76","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.canlet.2020.12.008","volume":"500","author":"L Sun","year":"2021","unstructured":"Sun L, Zhang X, Song Q, Liu L, Forbes E, Tian W, et al. IGFBP2 promotes tumor progression by inducing alternative polarization of macrophages in pancreatic ductal adenocarcinoma through the STAT3 pathway. Cancer Lett. 2021;500:132\u201346.","journal-title":"Cancer Lett"},{"key":"4243_CR77","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-003311","author":"DJ Pinato","year":"2021","unstructured":"Pinato DJ, Murray SM, Forner A, Kaneko T, Fessas P, Toniutto P, et al. Trans-arterial chemoembolization as a loco-regional inducer of immunogenic cell death in hepatocellular carcinoma: implications for immunotherapy. J Immunother Cancer. 2021;9:e003311. https:\/\/doi.org\/10.1136\/jitc-2021-003311.","journal-title":"J Immunother Cancer"},{"key":"4243_CR78","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.887916","volume":"13","author":"Q Wang","year":"2022","unstructured":"Wang Q, He Y, Li W, Xu X, Hu Q, Bian Z, et al. Soluble immune checkpoint-related proteins in blood are associated with invasion and progression in non-small cell lung cancer. Front Immunol. 2022;13:887916.","journal-title":"Front Immunol"},{"key":"4243_CR79","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1016\/j.ccell.2025.03.036","volume":"43","author":"JN Cheng","year":"2025","unstructured":"Cheng JN, Jin Z, Su C, Jiang T, Zheng X, Guo J, et al. Bone metastases diminish extraosseous response to checkpoint blockade immunotherapy through osteopontin-producing osteoclasts. Cancer Cell. 2025;43:1093-1107 e1099.","journal-title":"Cancer Cell"},{"key":"4243_CR80","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2021.5277","author":"K Kitayama","year":"2021","unstructured":"Kitayama K, Kawamoto T, Kawakami Y, Hara H, Takemori T, Fujiwara S, et al. Regulatory roles of miRNAs 16, 133a, and 223 on osteoclastic bone destruction caused by breast cancer metastasis. Int J Oncol. 2021;59:97. https:\/\/doi.org\/10.3892\/ijo.2021.5277.","journal-title":"Int J Oncol"},{"key":"4243_CR81","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.114528","volume":"43","author":"X Zhang","year":"2024","unstructured":"Zhang X, Liang X, Wen Y, Wu F, Gao G, Zhang L, et al. RAC1 inhibition ameliorates IBSP-induced bone metastasis in lung adenocarcinoma. Cell Rep. 2024;43:114528.","journal-title":"Cell Rep"},{"key":"4243_CR82","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.actbio.2023.05.038","volume":"166","author":"B Liu","year":"2023","unstructured":"Liu B, Yang Q, Cheng Y, Liu M, Ji Q, Zhang B, Yang Z, Zhou S, Liu D. Calcium phosphate hybrid micelles inhibit orthotopic bone metastasis from triple negative breast cancer by simultaneously killing cancer cells and reprogramming the microenvironment of bone resorption and immunosuppression. Acta Biomater. 2023;166:640\u201354.","journal-title":"Acta Biomater"},{"key":"4243_CR83","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.728047","volume":"11","author":"R Li","year":"2021","unstructured":"Li R, Zeng X, Yang M, Feng J, Xu X, Bao L, et al. Antidiabetic DPP-4 inhibitors reprogram tumor microenvironment that facilitates murine breast cancer metastasis through interaction with cancer cells via a ROS-NF-small ka, CyrillicB-NLRP3 axis. Front Oncol. 2021;11:728047.","journal-title":"Front Oncol"},{"key":"4243_CR84","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202310304","volume":"11","author":"X Luo","year":"2024","unstructured":"Luo X, Huang W, Li S, Sun M, Hu D, Jiang J, et al. SOX12 facilitates hepatocellular carcinoma progression and metastasis through promoting regulatory T-cells infiltration and immunosuppression. Adv Sci. 2024;11:e2310304.","journal-title":"Adv Sci"},{"key":"4243_CR85","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1038\/s41423-022-00903-z","volume":"19","author":"J Chen","year":"2022","unstructured":"Chen J, Zhao D, Zhang L, Zhang J, Xiao Y, Wu Q, Wang Y, Zhan Q. Tumor-associated macrophage (TAM)-derived CCL22 induces FAK addiction in esophageal squamous cell carcinoma (ESCC). Cell Mol Immunol. 2022;19:1054\u201366.","journal-title":"Cell Mol Immunol"},{"key":"4243_CR86","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11061517","author":"A Khabipov","year":"2023","unstructured":"Khabipov A, Trung DN, van der Linde J, Miebach L, Lenz M, Erne F, et al. CCR4 blockade diminishes intratumoral macrophage recruitment and augments survival of syngeneic pancreatic cancer-bearing mice. Biomedicines. 2023;11:1517. https:\/\/doi.org\/10.3390\/biomedicines11061517.","journal-title":"Biomedicines"},{"key":"4243_CR87","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-42167-1","volume":"13","author":"A Manda-Handzlik","year":"2023","unstructured":"Manda-Handzlik A, Cieloch A, Kuzmicka W, Mroczek A, Stelmaszczyk-Emmel A, Demkow U, et al. Secretomes of M1 and M2 macrophages decrease the release of neutrophil extracellular traps. Sci Rep. 2023;13:15633.","journal-title":"Sci Rep"},{"key":"4243_CR88","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-025-07685-y","volume":"16","author":"L Liu","year":"2025","unstructured":"Liu L, Wuyun T, Sun X, Zhang Y, Cha G, Zhao L. Therapeutic efficacy of TMTP1-modified EVs in overcoming bone metastasis and immune resistance in PIK3CA mutant NSCLC. Cell Death Dis. 2025;16:367.","journal-title":"Cell Death Dis"},{"key":"4243_CR89","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-024-05772-y","volume":"7","author":"F Ma","year":"2024","unstructured":"Ma F, Wang S, Xu L, Huang W, Shi G, Sun Z, et al. Single-cell profiling of the microenvironment in human bone metastatic renal cell carcinoma. Commun Biol. 2024;7:91.","journal-title":"Commun Biol"},{"key":"4243_CR90","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1016\/j.ijrobp.2023.10.031","volume":"118","author":"A Almeida","year":"2024","unstructured":"Almeida A, Godfroid C, Leavitt RJ, Montay-Gruel P, Petit B, Romero J, et al. Antitumor effect by either FLASH or conventional dose rate irradiation involves equivalent immune responses. Int J Radiat Oncol Biol Phys. 2024;118:1110\u201322.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"4243_CR91","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202415389","volume":"64","author":"IC Yoon","year":"2025","unstructured":"Yoon IC, Xue L, Chen Q, Liu J, Xu J, Siddiqui Z, et al. Piperazine-derived bisphosphonate-based ionizable lipid nanoparticles enhance mRNA delivery to the bone microenvironment. Angew Chem Int Ed Engl. 2025;64:e202415389.","journal-title":"Angew Chem Int Ed Engl"},{"key":"4243_CR92","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2023.122185","volume":"300","author":"SY Neshat","year":"2023","unstructured":"Neshat SY, Chan CHR, Harris J, Zmily OM, Est-Witte S, Karlsson J, et al. Polymeric nanoparticle gel for intracellular mRNA delivery and immunological reprogramming of tumors. Biomaterials. 2023;300:122185.","journal-title":"Biomaterials"},{"key":"4243_CR93","doi-asserted-by":"publisher","DOI":"10.1088\/1361-6528\/abcdcc","volume":"32","author":"C Zhang","year":"2021","unstructured":"Zhang C, Li Q, Wu C, Wang J, Su M, Deng J. Hypoxia-responsive nanogel as IL-12 carrier for anti-cancer therapy. Nanotechnology. 2021;32:095107.","journal-title":"Nanotechnology"},{"key":"4243_CR94","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202409593","volume":"21","author":"Y Yang","year":"2025","unstructured":"Yang Y, Liu X, Zhang R, Liu Y, Zhou N, Jiang Y. Size-tunable micro-nano liposomes: enhanced lung targeting and tumor penetration for combination treatment of lung cancer. Small. 2025;21:e2409593.","journal-title":"Small"},{"key":"4243_CR95","doi-asserted-by":"publisher","first-page":"3295","DOI":"10.1021\/acsnano.3c10037","volume":"18","author":"Y Hu","year":"2024","unstructured":"Hu Y, Nie W, Lyu L, Zhang X, Wang W, Zhang Y, et al. Tumor-microenvironment-activatable nanoparticle mediating immunogene therapy and M2 macrophage-targeted inhibitor for synergistic cancer immunotherapy. ACS Nano. 2024;18:3295\u2013312.","journal-title":"ACS Nano"},{"key":"4243_CR96","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1410564","volume":"15","author":"OA Rakitina","year":"2024","unstructured":"Rakitina OA, Kuzmich AI, Bezborodova OA, Kondratieva SA, Pleshkan VV, Zinovyeva MV, et al. Non-viral-mediated gene transfer of OX40 ligand for tumor immunotherapy. Front Immunol. 2024;15:1410564.","journal-title":"Front Immunol"},{"key":"4243_CR97","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202419182","volume":"37","author":"S Liang","year":"2025","unstructured":"Liang S, Gao S, Fu S, Yuan S, Liu J, Liang M, et al. Screening natural cholesterol analogs to assemble self-adjuvant lipid nanoparticles for antigens tagging guided therapeutic tumor vaccine. Adv Mater. 2025;37:e2419182.","journal-title":"Adv Mater"},{"key":"4243_CR98","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1021\/acs.accounts.0c00341","volume":"53","author":"K Adu-Berchie","year":"2020","unstructured":"Adu-Berchie K, Mooney DJ. Biomaterials as local niches for immunomodulation. Acc Chem Res. 2020;53:1749\u201360.","journal-title":"Acc Chem Res"},{"key":"4243_CR99","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2021.120897","volume":"275","author":"Z Geng","year":"2021","unstructured":"Geng Z, Chen F, Wang X, Wang L, Pang Y, Liu J. Combining anti-PD-1 antibodies with Mn(2+)-drug coordinated multifunctional nanoparticles for enhanced cancer therapy. Biomaterials. 2021;275:120897.","journal-title":"Biomaterials"},{"key":"4243_CR100","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.jconrel.2024.07.039","volume":"373","author":"Y Li","year":"2024","unstructured":"Li Y, Yi J, Ma R, Wang Y, Lou X, Dong Y, et al. A polymeric nanoplatform enhances the cGAS-STING pathway in macrophages to potentiate phagocytosis for cancer immunotherapy. J Control Release. 2024;373:447\u201362.","journal-title":"J Control Release"},{"key":"4243_CR101","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1097\/RLI.0000000000001030","volume":"59","author":"R Roudi","year":"2024","unstructured":"Roudi R, Pisani L, Pisani F, Kiru L, Daldrup-Link HE. Novel clinically translatable iron oxide nanoparticle for monitoring anti-CD47 cancer immunotherapy. Invest Radiol. 2024;59:391\u2013403.","journal-title":"Invest Radiol"},{"key":"4243_CR102","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-025-02253-6","volume":"24","author":"L Zhang","year":"2025","unstructured":"Zhang L, Lin Y, Hu L, Wang Y, Hu C, Shangguan X, et al. Transient intracellular expression of PD-L1 and VEGFR2 bispecific nanobody in cancer cells inspires long-term T cell activation and infiltration to combat tumor and inhibit cancer metastasis. Mol Cancer. 2025;24:119.","journal-title":"Mol Cancer"},{"key":"4243_CR103","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-001458","author":"AM Starzer","year":"2021","unstructured":"Starzer AM, Berghoff AS, Hamacher R, Tomasich E, Feldmann K, Hatziioannou T, et al. Tumor DNA methylation profiles correlate with response to anti-PD-1 immune checkpoint inhibitor monotherapy in sarcoma patients. J Immunother Cancer. 2021;9:e001458. https:\/\/doi.org\/10.1136\/jitc-2020-001458.","journal-title":"J Immunother Cancer"},{"key":"4243_CR104","doi-asserted-by":"publisher","first-page":"e0236891","DOI":"10.1371\/journal.pone.0236891","volume":"15","author":"RK Davidson","year":"2020","unstructured":"Davidson RK, Himes ER, Takigawa S, Chen A, Horn MR, Meijome T, et al. The loss of STAT3 in mature osteoclasts has detrimental effects on bone structure. PLoS One. 2020;15:e0236891.","journal-title":"PLoS One"},{"key":"4243_CR105","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a041635","author":"EP Young","year":"2024","unstructured":"Young EP, Marinoff AE, Lopez-Fuentes E, Sweet-Cordero EA. Osteosarcoma through the lens of bone development, signaling, and microenvironment. Cold Spring Harb Perspect Med. 2024;14:a041635. https:\/\/doi.org\/10.1101\/cshperspect.a041635.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"4243_CR106","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.jconrel.2024.07.067","volume":"373","author":"X Hao","year":"2024","unstructured":"Hao X, Jiang B, Wu J, Xiang D, Xiong Z, Li C, Li Z, He S, Tu C, Li Z. Nanomaterials for bone metastasis. J Control Release. 2024;373:640\u201351.","journal-title":"J Control Release"},{"key":"4243_CR107","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1021\/acs.nanolett.9b02916","volume":"20","author":"Y Pang","year":"2020","unstructured":"Pang Y, Fu Y, Li C, Wu Z, Cao W, Hu X, et al. Metal-organic framework nanoparticles for ameliorating breast cancer-associated osteolysis. Nano Lett. 2020;20:829\u201340.","journal-title":"Nano Lett"},{"key":"4243_CR108","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-025-01291-z","volume":"15","author":"RAL de Groen","year":"2025","unstructured":"de Groen RAL, de Groot FA, Bohringer S, Kret EJ, de Haan LM, Noordenbos T, et al. Superior survival in diffuse large B cell lymphoma of the bone with immune rich tumor microenvironment. Blood Cancer J. 2025;15:82.","journal-title":"Blood Cancer J"},{"key":"4243_CR109","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202404501","volume":"14","author":"Y He","year":"2025","unstructured":"He Y, Lu Y, Li R, Tang Y, Du W, Zhang L, et al. CircAars-engineered ADSCs facilitate maxillofacial bone defects repair via synergistic capability of osteogenic differentiation, macrophage polarization and angiogenesis. Adv Healthc Mater. 2025;14:e2404501.","journal-title":"Adv Healthc Mater"},{"key":"4243_CR110","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110848","volume":"132","author":"J Han","year":"2020","unstructured":"Han J, Li X, Luo X, He J, Huang X, Zhou Q, et al. The mechanisms of hydroxychloroquine in rheumatoid arthritis treatment: inhibition of dendritic cell functions via Toll like receptor 9 signaling. Biomed Pharmacother. 2020;132:110848.","journal-title":"Biomed Pharmacother"},{"key":"4243_CR111","doi-asserted-by":"publisher","DOI":"10.3390\/bios12020071","author":"H Chen","year":"2022","unstructured":"Chen H, Zhang Y, Li L, Guo R, Shi X, Cao X. Effective CpG delivery using zwitterion-functionalized dendrimer-entrapped gold nanoparticles to promote T cell-mediated immunotherapy of cancer cells. Biosensors. 2022;12:71. https:\/\/doi.org\/10.3390\/bios12020071.","journal-title":"Biosensors"},{"key":"4243_CR112","doi-asserted-by":"publisher","first-page":"5329","DOI":"10.1021\/acsbiomaterials.2c00880","volume":"8","author":"S Zhang","year":"2022","unstructured":"Zhang S, Wu Y, Yu J, Ma C, Wang Y, Wang Y, et al. Gadolinium-bisphosphonate nanoparticle-based low-dose radioimmunotherapy for osteosarcoma. ACS Biomater Sci Eng. 2022;8:5329\u201337.","journal-title":"ACS Biomater Sci Eng"},{"key":"4243_CR113","doi-asserted-by":"publisher","first-page":"17014","DOI":"10.1021\/acsnano.5c04743","volume":"19","author":"Z Li","year":"2025","unstructured":"Li Z, Xiao X, Pu X, Yang X, Shi J, He S, et al. Bone-targeting nucleic acid delivery polymer vector for effective therapy of bone metastasis. ACS Nano. 2025;19:17014\u201327.","journal-title":"ACS Nano"},{"key":"4243_CR114","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2022.112826","volume":"219","author":"Y Shen","year":"2022","unstructured":"Shen Y, Lv Y. Dual targeted zeolitic imidazolate framework nanoparticles for treating metastatic breast cancer and inhibiting bone destruction. Colloids Surf B Biointerfaces. 2022;219:112826.","journal-title":"Colloids Surf B Biointerfaces"},{"key":"4243_CR115","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/j.jconrel.2022.12.016","volume":"353","author":"F Mpekris","year":"2023","unstructured":"Mpekris F, Panagi M, Michael C, Voutouri C, Tsuchiya M, Wagatsuma C, et al. Translational nanomedicine potentiates immunotherapy in sarcoma by normalizing the microenvironment. J Control Release. 2023;353:956\u201364.","journal-title":"J Control Release"},{"key":"4243_CR116","doi-asserted-by":"publisher","first-page":"3597","DOI":"10.1016\/j.ymthe.2024.07.014","volume":"32","author":"HY Kim","year":"2024","unstructured":"Kim HY, Cho S, Kim SB, Song EC, Jung W, Shin YG, et al. Specific targeting of cancer vaccines to antigen-presenting cells via an endogenous TLR2\/6 ligand derived from cysteinyl-tRNA synthetase 1. Mol Ther. 2024;32:3597\u2013617.","journal-title":"Mol Ther"},{"key":"4243_CR117","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01794-4","volume":"9","author":"C Wang","year":"2024","unstructured":"Wang C, Xu J, Cheng X, Sun G, Li F, Nie G, et al. Anti-lymphangiogenesis for boosting drug accumulation in tumors. Signal Transduct Target Ther. 2024;9:89.","journal-title":"Signal Transduct Target Ther"},{"key":"4243_CR118","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtbio.2023.100675","volume":"20","author":"D Xiang","year":"2023","unstructured":"Xiang D, Han X, Li J, Zhang J, Xiao H, Li T, et al. Combination of IDO inhibitors and platinum(IV) prodrugs reverses low immune responses to enhance cancer chemotherapy and immunotherapy for osteosarcoma. Mater Today Bio. 2023;20:100675.","journal-title":"Mater Today Bio"},{"key":"4243_CR119","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2022.121407","volume":"282","author":"YX Ge","year":"2022","unstructured":"Ge YX, Zhang TW, Zhou L, Ding W, Liang HF, Hu ZC, et al. Enhancement of anti-PD-1\/PD-L1 immunotherapy for osteosarcoma using an intelligent autophagy-controlling metal organic framework. Biomaterials. 2022;282:121407.","journal-title":"Biomaterials"},{"key":"4243_CR120","doi-asserted-by":"publisher","DOI":"10.1172\/JCI176851","author":"S Wang","year":"2024","unstructured":"Wang S, Huang T, Wu Q, Yuan H, Wu X, Yuan F, et al. Lactate reprograms glioblastoma immunity through CBX3-regulated histone lactylation. J Clin Invest. 2024;134:e176851. https:\/\/doi.org\/10.1172\/JCI176851.","journal-title":"J Clin Invest"},{"key":"4243_CR121","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-025-03485-w","volume":"23","author":"H Liao","year":"2025","unstructured":"Liao H, Chen M, Liao Z, Luo Y, Chen S, Tan W, et al. Sonodynamic therapy-boosted biomimetic nanoplatform targets ferroptosis and CD47 as vulnerabilities for cancer immunotherapy. J Nanobiotechnology. 2025;23:432.","journal-title":"J Nanobiotechnology"},{"key":"4243_CR122","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-1285-3","volume":"10","author":"S Mohanty","year":"2019","unstructured":"Mohanty S, Yerneni K, Theruvath JL, Graef CM, Nejadnik H, Lenkov O, et al. Nanoparticle enhanced MRI can monitor macrophage response to CD47 mAb immunotherapy in osteosarcoma. Cell Death Dis. 2019;10:36.","journal-title":"Cell Death Dis"},{"key":"4243_CR123","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.130915","volume":"267","author":"J Cao","year":"2024","unstructured":"Cao J, Zhu C, Cao Z, Ke X. CPPs-modified chitosan as permeability-enhancing chemotherapeutic combined with gene therapy nanosystem by thermosensitive hydrogel for the treatment of osteosarcoma. Int J Biol Macromol. 2024;267:130915.","journal-title":"Int J Biol Macromol"},{"key":"4243_CR124","first-page":"248","volume":"47","author":"X Ji","year":"2025","unstructured":"Ji X, Qian X, Luo G, Yang W, Huang W, Lei Z, Zhou J, Zhong G, Zhou J, Liu N, et al. Engineered macrophage nanoparticles enhance microwave ablation efficacy in osteosarcoma via targeting the CD47-SIRPalpha Axis: A novel Biomimetic immunotherapeutic approach. Bioact Mater. 2025;47:248\u201365.","journal-title":"Bioact Mater"},{"key":"4243_CR125","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202309038","volume":"20","author":"J Dong","year":"2024","unstructured":"Dong J, Chai X, Xue Y, Shen S, Chen Z, Wang Z, et al. ZIF-8-encapsulated pexidartinib delivery via targeted peptide-modified M1 macrophages attenuates MDSC-mediated immunosuppression in osteosarcoma. Small. 2024;20:e2309038.","journal-title":"Small"},{"key":"4243_CR126","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.actbio.2024.12.048","volume":"193","author":"J Yan","year":"2025","unstructured":"Yan J, Wei D, Zhao Z, Sun K, Sun Y. Osteosarcoma-targeting Pt(IV) prodrug amphiphile for enhanced chemo-immunotherapy via Ca(2+) trapping. Acta Biomater. 2025;193:474\u201383.","journal-title":"Acta Biomater"},{"key":"4243_CR127","doi-asserted-by":"publisher","first-page":"691","DOI":"10.32604\/or.2023.030767","volume":"32","author":"J Xiao","year":"2024","unstructured":"Xiao J, Xiao H, Cai Y, Liao J, Liu J, Yao L, Li S. Codelivery of anti-CD47 antibody and chlorin e6 using a dual pH-sensitive nanodrug for photodynamic immunotherapy of osteosarcoma. Oncol Res. 2024;32:691\u2013702.","journal-title":"Oncol Res"},{"key":"4243_CR128","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1173487","volume":"14","author":"J Yang","year":"2023","unstructured":"Yang J, Guo W, Huang R, Bian J, Zhang S, Wei T, et al. Self-assembled albumin nanoparticles induce pyroptosis for photodynamic\/photothermal\/immuno synergistic therapies in triple-negative breast cancer. Front Immunol. 2023;14:1173487.","journal-title":"Front Immunol"},{"key":"4243_CR129","doi-asserted-by":"publisher","DOI":"10.1093\/nsr\/nwaf002","volume":"12","author":"S Lu","year":"2025","unstructured":"Lu S, Yang Y, Song Z, Cao J, Han Z, Chen L, et al. Dual functional nanoplatforms potentiate osteosarcoma immunotherapy via microenvironment modulation. Natl Sci Rev. 2025;12:nwaf002.","journal-title":"Natl Sci Rev"},{"key":"4243_CR130","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aax5032","volume":"6","author":"KW Huang","year":"2020","unstructured":"Huang KW, Hsu FF, Qiu JT, Chern GJ, Lee YA, Chang CC, et al. Highly efficient and tumor-selective nanoparticles for dual-targeted immunogene therapy against cancer. Sci Adv. 2020;6:eaax5032.","journal-title":"Sci Adv"},{"key":"4243_CR131","doi-asserted-by":"publisher","first-page":"19901","DOI":"10.1021\/acsnano.5c02846","volume":"19","author":"Z Gu","year":"2025","unstructured":"Gu Z, Li L, Xu P, Li C, Liu B, Zhu P, et al. Multimodal regulation of dendritic cells via mineralized vaccines for postsurgical tumor relapse prevention. ACS Nano. 2025;19:19901\u201317.","journal-title":"ACS Nano"},{"key":"4243_CR132","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2025.113722","volume":"382","author":"C Neophytou","year":"2025","unstructured":"Neophytou C, Charalambous A, Voutouri C, Angeli S, Panagi M, Stylianopoulos T, et al. Sonopermeation combined with stroma normalization enables complete cure using nano-immunotherapy in murine breast tumors. J Control Release. 2025;382:113722.","journal-title":"J Control Release"},{"key":"4243_CR133","doi-asserted-by":"publisher","DOI":"10.1080\/23723556.2017.1333973","volume":"4","author":"VT Chin","year":"2017","unstructured":"Chin VT, Vennin C, Timpson P, Pajic M. Effective modulation of stromal signaling through ROCK inhibition: is it all in the timing? Molecular & Cellular Oncology. 2017;4:e1333973.","journal-title":"Molecular & Cellular Oncology"},{"key":"4243_CR134","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1158\/1535-7163.MCT-23-0772","volume":"23","author":"A Charalambous","year":"2024","unstructured":"Charalambous A, Mpekris F, Panagi M, Voutouri C, Michael C, Gabizon AA, et al. Tumor microenvironment reprogramming improves nanomedicine-based chemo-immunotherapy in sarcomas. Mol Cancer Ther. 2024;23:1555\u201367.","journal-title":"Mol Cancer Ther"},{"key":"4243_CR135","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.canlet.2018.10.020","volume":"442","author":"AA De Vera","year":"2019","unstructured":"De Vera AA, Gupta P, Lei Z, Liao D, Narayanan S, Teng Q, et al. Immuno-oncology agent IPI-549 is a modulator of P-glycoprotein (P-gp, MDR1, ABCB1)-mediated multidrug resistance (MDR) in cancer: in vitro and in vivo. Cancer Lett. 2019;442:91\u2013103.","journal-title":"Cancer Lett"},{"key":"4243_CR136","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-025-02352-4","volume":"24","author":"Y Senent","year":"2025","unstructured":"Senent Y, Fresquet V, Jimenez V, Valencia K, Exposito F, Martin-Uriz PS, et al. Co-targeting of epigenetic regulators and BCL-XL improves efficacy of immune checkpoint blockade therapy in multiple solid tumors. Mol Cancer. 2025;24:154.","journal-title":"Mol Cancer"},{"key":"4243_CR137","doi-asserted-by":"publisher","first-page":"67225","DOI":"10.1021\/acsami.4c12532","volume":"16","author":"Z Yu","year":"2024","unstructured":"Yu Z, Gan Z, Wu W, Sun X, Cheng X, Chen C, et al. Photothermal-triggered extracellular matrix clearance and dendritic cell maturation for enhanced osteosarcoma immunotherapy. ACS Appl Mater Interfaces. 2024;16:67225\u201334.","journal-title":"ACS Appl Mater Interfaces"},{"key":"4243_CR138","first-page":"182","volume":"52","author":"G Zhong","year":"2025","unstructured":"Zhong G, Miao Y, Zhou J, He Y, Yang W, Huang C, et al. Near-infrared light-induced photothermal and immunotherapy system for lung cancer bone metastasis treatment with simultaneous bone repair. Bioact Mater. 2025;52:182\u201399.","journal-title":"Bioact Mater"},{"key":"4243_CR139","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202400623","volume":"13","author":"K Liu","year":"2024","unstructured":"Liu K, Zan P, Li Z, Lu H, Liu P, Zhang L, et al. Engineering bimetallic polyphenol for mild photothermal osteosarcoma therapy and immune microenvironment remodeling by activating pyroptosis and cGAS-STING pathway. Adv Healthc Mater. 2024;13:e2400623.","journal-title":"Adv Healthc Mater"},{"key":"4243_CR140","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202415814","volume":"37","author":"X Wang","year":"2025","unstructured":"Wang X, Guo X, Ren H, Song X, Chen L, Yu L, et al. An \u201cOuter Piezoelectric and Inner Epigenetic\u201d Logic-Gated PANoptosis for osteosarcoma sono-immunotherapy and bone regeneration. Adv Mater. 2025;37:e2415814.","journal-title":"Adv Mater"},{"key":"4243_CR141","doi-asserted-by":"publisher","first-page":"8538","DOI":"10.1021\/acsami.3c18171","volume":"16","author":"C Gong","year":"2024","unstructured":"Gong C, Wang J, Tang F, Tong D, Wang Z, Zhou Z, et al. Bionic bilayer scaffold for synchronous hyperthermia therapy of orthotopic osteosarcoma and osteochondral regeneration. ACS Appl Mater Interfaces. 2024;16:8538\u201353.","journal-title":"ACS Appl Mater Interfaces"},{"key":"4243_CR142","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmbbm.2023.106306","volume":"150","author":"W Li","year":"2024","unstructured":"Li W, Yang Y, Wang J, Ge T, Wan S, Gui L, et al. Establishment of bone-targeted nano-platform and the study of its combination with 2-deoxy-d-glucose enhanced photodynamic therapy to inhibit bone metastasis. J Mech Behav Biomed Mater. 2024;150:106306.","journal-title":"J Mech Behav Biomed Mater"},{"key":"4243_CR143","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1039\/D1BM01717A","volume":"10","author":"T Ge","year":"2022","unstructured":"Ge T, Weiwei Z, Ge F, Zhu L, Song P, Li W, Gui L, Dong W, Tao Y, Yang K. A bone-targeting drug delivery vehicle of a metal-organic framework conjugate with zoledronate combined with photothermal therapy for tumor inhibition in cancer bone metastasis. Biomater Sci. 2022;10:1831\u201343.","journal-title":"Biomater Sci"},{"key":"4243_CR144","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtbio.2023.100547","volume":"19","author":"YX Ge","year":"2023","unstructured":"Ge YX, Zhuang HJ, Zhang TW, Liang HF, Ding W, Zhou L, et al. Precise manipulation of circadian clock using MnO(2) nanocapsules to amplify photodynamic therapy for osteosarcoma. Mater Today Bio. 2023;19:100547.","journal-title":"Mater Today Bio"},{"key":"4243_CR145","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1039\/D2BM01081J","volume":"11","author":"K Liu","year":"2022","unstructured":"Liu K, Liu H, Li C, Xie Z, Zheng M. Ultra-small NIR J-aggregates of BODIPY for potent phototheranostics. Biomater Sci. 2022;11:195\u2013207.","journal-title":"Biomater Sci"},{"key":"4243_CR146","doi-asserted-by":"publisher","first-page":"e2411733","DOI":"10.1002\/advs.202411733","volume":"12","author":"Q Zhao","year":"2025","unstructured":"Zhao Q, Wu C, Gao Y, Long J, Zhang W, Chen Y, Yang Y, Luo Y, Lai Y, Zhang H, et al. NIR-II Emissive Persistent Neutral pi-Radical with Rapid Doublet Internal Conversion for Efficient Cancer Photothermal Theranostics. Adv Sci (Weinh). 2025;12:e2411733.","journal-title":"Adv Sci (Weinh)"},{"key":"4243_CR147","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2024.1485549","volume":"12","author":"X Zhang","year":"2024","unstructured":"Zhang X, Wang J, Feng Q, Lei L, Zhu Z. Manganese-pyrochloric acid photosensitizer nanocomplexes against osteosarcoma: achieving both high activatability and high effectiveness. Front Bioeng Biotechnol. 2024;12:1485549.","journal-title":"Front Bioeng Biotechnol"},{"key":"4243_CR148","doi-asserted-by":"publisher","first-page":"6729","DOI":"10.1039\/C9AN01530B","volume":"144","author":"F Du","year":"2019","unstructured":"Du F, Zhao X, Lu W, Guo Z, Shuang S, Dong C. Dual-ligand functionalized carbon nanodots as green fluorescent nanosensors for cellular dual receptor-mediated targeted imaging. Analyst. 2019;144:6729\u201335.","journal-title":"Analyst"},{"key":"4243_CR149","doi-asserted-by":"publisher","first-page":"10513","DOI":"10.2147\/IJN.S477027","volume":"19","author":"X Cheng","year":"2024","unstructured":"Cheng X, Pan R, Tang J, Yu K, Zhang H, Zhao X. Preliminary study on pharmacokinetics and antitumor pharmacodynamics of folic acid modified crebanine polyethyleneglycol-polylactic acid hydroxyacetic acid copolymer nanoparticles. Int J Nanomed. 2024;19:10513\u201336.","journal-title":"Int J Nanomed"},{"key":"4243_CR150","doi-asserted-by":"publisher","DOI":"10.1186\/s40824-023-00465-9","volume":"27","author":"L Lv","year":"2023","unstructured":"Lv L, Shi Y, Deng Z, Xu J, Ye Z, He J, et al. A polymeric nanocarrier that eradicates breast cancer stem cells and delivers chemotherapeutic drugs. Biomater Res. 2023;27:133.","journal-title":"Biomater Res"},{"key":"4243_CR151","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2021.629928","volume":"9","author":"Y Xu","year":"2021","unstructured":"Xu Y, Zhang Z, Wang H, Zhong W, Sun C, Sun W, et al. Zoledronic acid-loaded hybrid hyaluronic acid\/polyethylene glycol\/nano-hydroxyapatite nanoparticle: novel fabrication and safety verification. Front Bioeng Biotechnol. 2021;9:629928.","journal-title":"Front Bioeng Biotechnol"},{"key":"4243_CR152","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15072014","author":"F Luo","year":"2023","unstructured":"Luo F, Zhong T, Chen Y, Guo Q, Tao L, Shen X, et al. Dual-ligand synergistic targeting anti-tumor nanoplatforms with cascade-responsive drug release. Pharmaceutics. 2023;15:2014. https:\/\/doi.org\/10.3390\/pharmaceutics15072014.","journal-title":"Pharmaceutics"},{"key":"4243_CR153","doi-asserted-by":"publisher","first-page":"3853","DOI":"10.2147\/IJN.S150017","volume":"13","author":"F Haghiralsadat","year":"2018","unstructured":"Haghiralsadat F, Amoabediny G, Naderinezhad S, Zandieh-Doulabi B, Forouzanfar T, Helder MN. Codelivery of doxorubicin and JIP1 siRNA with novel EphA2-targeted PEGylated cationic nanoliposomes to overcome osteosarcoma multidrug resistance. Int J Nanomed. 2018;13:3853\u201366.","journal-title":"Int J Nanomed"},{"key":"4243_CR154","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-57965-6","volume":"16","author":"Y Liu","year":"2025","unstructured":"Liu Y, Xie Y, Chen Y, Duan J, Bao C, Wang J, et al. A protease-cleavable liposome for co-delivery of anti-PD-L1 and doxorubicin for colon cancer therapy in mice. Nat Commun. 2025;16:2854.","journal-title":"Nat Commun"},{"key":"4243_CR155","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-019-0445-7","volume":"17","author":"DG Zayed","year":"2019","unstructured":"Zayed DG, Ebrahim SM, Helmy MW, Khattab SN, Bahey-El-Din M, Fang JY, et al. Combining hydrophilic chemotherapy and hydrophobic phytotherapy via tumor-targeted albumin-QDs nano-hybrids: covalent coupling and phospholipid complexation approaches. J Nanobiotechnol. 2019;17:7.","journal-title":"J Nanobiotechnol"},{"key":"4243_CR156","doi-asserted-by":"publisher","first-page":"8603","DOI":"10.2147\/IJN.S218988","volume":"14","author":"H Wei","year":"2019","unstructured":"Wei H, Chen J, Wang S, Fu F, Zhu X, Wu C, et al. A nanodrug consisting of doxorubicin and exosome derived from mesenchymal stem cells for osteosarcoma treatment in vitro. Int J Nanomed. 2019;14:8603\u201310.","journal-title":"Int J Nanomed"},{"key":"4243_CR157","doi-asserted-by":"publisher","first-page":"8429","DOI":"10.1039\/D4DT00371C","volume":"53","author":"M Strimaite","year":"2024","unstructured":"Strimaite M, Wells CJR, Prior TJ, Stuckey DJ, Wells JA, Davies GL, Williams GR. Layered rare-earth hydroxides as multi-modal medical imaging probes: particle size optimisation and compositional exploration. Dalton Trans. 2024;53:8429\u201342.","journal-title":"Dalton Trans"},{"key":"4243_CR158","doi-asserted-by":"publisher","first-page":"7466","DOI":"10.1021\/acsbiomaterials.4c00952","volume":"10","author":"S Samal","year":"2024","unstructured":"Samal S, Panda GP, Shyamal S, Das K, Dash M. Surface engineered osteoblast-extracellular vesicles serve as an efficient carrier for drug and small RNA to actively target osteosarcoma. ACS Biomater Sci Eng. 2024;10:7466\u201381.","journal-title":"ACS Biomater Sci Eng"},{"key":"4243_CR159","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-024-02517-1","volume":"22","author":"Z Lin","year":"2024","unstructured":"Lin Z, Xu G, Lu X, Liu S, Zou F, Ma X, et al. Chondrocyte-targeted exosome-mediated delivery of Nrf2 alleviates cartilaginous endplate degeneration by modulating mitochondrial fission. J Nanobiotechnol. 2024;22:281.","journal-title":"J Nanobiotechnol"},{"key":"4243_CR160","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202400114","author":"Q Yu","year":"2024","unstructured":"Yu Q, Gao Y, Dai W, Li D, Zhang L, Hameed MMA, et al. Cell membrane-camouflaged chitosan-polypyrrole nanogels co-deliver drug and gene for targeted chemotherapy and bone metastasis inhibition of prostate cancer. Adv Healthc Mater. 2024;13:e2400114. https:\/\/doi.org\/10.1002\/adhm.202400114.","journal-title":"Adv Healthc Mater"},{"key":"4243_CR161","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-023-01272-6","volume":"16","author":"S Mei","year":"2024","unstructured":"Mei S, Alchahin AM, Tsea I, Kfoury Y, Hirz T, Jeffries NE, et al. Single-cell analysis of immune and stroma cell remodeling in clear cell renal cell carcinoma primary tumors and bone metastatic lesions. Genome Med. 2024;16:1.","journal-title":"Genome Med"},{"key":"4243_CR162","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-06806-3","volume":"15","author":"J Ouyang","year":"2024","unstructured":"Ouyang J, Hu S, Zhu Q, Li C, Kang T, Xie W, et al. RANKL\/RANK signaling recruits Tregs via the CCL20-CCR6 pathway and promotes stemness and metastasis in colorectal cancer. Cell Death Dis. 2024;15:437.","journal-title":"Cell Death Dis"},{"key":"4243_CR163","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-024-01525-w","volume":"22","author":"X Peng","year":"2024","unstructured":"Peng X, Wang T, Wang Q, Zhao Y, Xu H, Yang H, et al. Pan-histone deacetylase inhibitor vorinostat suppresses osteoclastic bone resorption through modulation of RANKL-evoked signaling and ameliorates ovariectomy-induced bone loss. Cell Commun Signal. 2024;22:160.","journal-title":"Cell Commun Signal"},{"key":"4243_CR164","doi-asserted-by":"publisher","first-page":"3291","DOI":"10.1080\/10717544.2022.2141921","volume":"29","author":"J Wang","year":"2022","unstructured":"Wang J, Li M, Jin L, Guo P, Zhang Z, Zhanghuang C, et al. Exosome mimetics derived from bone marrow mesenchymal stem cells deliver doxorubicin to osteosarcoma in vitro and in vivo. Drug Deliv. 2022;29:3291\u2013303.","journal-title":"Drug Deliv"},{"key":"4243_CR165","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-023-01871-w","volume":"21","author":"Z Yang","year":"2023","unstructured":"Yang Z, Li X, Gan X, Wei M, Wang C, Yang G, et al. Hydrogel armed with Bmp2 mRNA-enriched exosomes enhances bone regeneration. J Nanobiotechnology. 2023;21:119.","journal-title":"J Nanobiotechnology"},{"key":"4243_CR166","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-025-03772-6","volume":"23","author":"Z Liao","year":"2025","unstructured":"Liao Z, Ou Z, Tong B, Li S, Yang C. Customized extracellular vesicles targeting lysosomal biogenesis deliver therapeutic cargo for intervertebral disc degeneration treatment. J Nanobiotechnology. 2025;23:659.","journal-title":"J Nanobiotechnology"},{"key":"4243_CR167","doi-asserted-by":"publisher","first-page":"2516","DOI":"10.1021\/acs.bioconjchem.1c00492","volume":"32","author":"S Kanwal","year":"2021","unstructured":"Kanwal S, Naveed M, Arshad A, Arshad A, Firdous F, Faisal A, et al. Reduction-sensitive dextran-paclitaxel polymer-drug conjugate: synthesis, self-assembly into nanoparticles, and in vitro anticancer efficacy. Bioconjug Chem. 2021;32:2516\u201329.","journal-title":"Bioconjug Chem"},{"key":"4243_CR168","doi-asserted-by":"publisher","first-page":"11349","DOI":"10.1039\/D1NR02188E","volume":"13","author":"S Bobbala","year":"2021","unstructured":"Bobbala S, Vincent MP, Scott EA. Just add water: hydratable, morphologically diverse nanocarrier powders for targeted delivery. Nanoscale. 2021;13:11349\u201359.","journal-title":"Nanoscale"},{"key":"4243_CR169","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.679610","volume":"12","author":"J Chen","year":"2021","unstructured":"Chen J, Qian C, Ren P, Yu H, Kong X, Huang C, et al. Light-responsive micelles loaded with doxorubicin for osteosarcoma suppression. Front Pharmacol. 2021;12:679610.","journal-title":"Front Pharmacol"},{"key":"4243_CR170","doi-asserted-by":"publisher","DOI":"10.3390\/polym12112749","author":"A Beagan","year":"2020","unstructured":"Beagan A, Lahmadi S, Alghamdi A, Halwani M, Almeataq M, Alhazaa A, et al. Glucosamine modified the surface of pH-responsive poly(2-(diethylamino)ethyl methacrylate) brushes grafted on hollow mesoporous silica nanoparticles as smart nanocarrier. Polymers (Basel). 2020;12:2749. https:\/\/doi.org\/10.3390\/polym12112749.","journal-title":"Polymers (Basel)"},{"key":"4243_CR171","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202300154","volume":"12","author":"J Ge","year":"2023","unstructured":"Ge J, Tan R, Gao Q, Li R, Xu P, Song H, et al. A multifunctional nanocarrier system for highly efficient and targeted delivery of ketamine to NMDAR sites for improved treatment of depression. Adv Healthc Mater. 2023;12:e2300154.","journal-title":"Adv Healthc Mater"},{"key":"4243_CR172","doi-asserted-by":"publisher","DOI":"10.3389\/fchem.2024.1386076","volume":"12","author":"Y Tao","year":"2024","unstructured":"Tao Y, Li L, Yang X, Yin S, Zhang Z, Wang H, et al. Magnetic-driven hydrogel microrobots for promoting osteosarcoma chemo-therapy with synthetic lethality strategy. Front Chem. 2024;12:1386076.","journal-title":"Front Chem"},{"key":"4243_CR173","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.900080","volume":"13","author":"Y Xu","year":"2022","unstructured":"Xu Y, Zhou Z, Brooks B, Ferguson T, Obliosca J, Huang J, et al. Layer-by-layer delivery of multiple antigens using trimethyl chitosan nanoparticles as a malaria vaccine candidate. Front Immunol. 2022;13:900080.","journal-title":"Front Immunol"},{"key":"4243_CR174","doi-asserted-by":"publisher","DOI":"10.3390\/polym13183170","author":"M Sadiq","year":"2021","unstructured":"Sadiq M, Mazhar U, Shah GA, Hassan Z, Iqbal Z, Mahmood I, et al. Zinc plus biopolymer coating slows nitrogen release, decreases ammonia volatilization from urea and improves sunflower productivity. Polymers. 2021;13:3170. https:\/\/doi.org\/10.3390\/polym13183170.","journal-title":"Polymers"},{"key":"4243_CR175","doi-asserted-by":"publisher","first-page":"5935","DOI":"10.1021\/acsbiomaterials.9b00841","volume":"5","author":"M Zhang","year":"2019","unstructured":"Zhang M, Gong Z, Zhang J, Cheng H, Chen J, Zeng Y, et al. Engineered zinc titanate coatings on the titanium surface with enhanced antitumor properties and biocompatibility. ACS Biomater Sci Eng. 2019;5:5935\u201346.","journal-title":"ACS Biomater Sci Eng"},{"key":"4243_CR176","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtbio.2022.100227","volume":"14","author":"Y Liu","year":"2022","unstructured":"Liu Y, Nadeem A, Sebastian S, Olsson MA, Wai SN, Styring E, et al. Bone mineral: a trojan horse for bone cancers. Efficient mitochondria targeted delivery and tumor eradication with nano hydroxyapatite containing doxorubicin. Mater Today Bio. 2022;14:100227.","journal-title":"Mater Today Bio"},{"key":"4243_CR177","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.138793","volume":"290","author":"S Vijayakumar","year":"2025","unstructured":"Vijayakumar S, Gonzalez-Sanchez ZI, Amanullah M, Sonamuthu J, Rajkumar M, Divya M, et al. Shark chondroitin sulfate gold nanoparticles: a biocompatible apoptotic agent for osteosarcoma. Int J Biol Macromol. 2025;290:138793.","journal-title":"Int J Biol Macromol"},{"key":"4243_CR178","doi-asserted-by":"publisher","first-page":"34365","DOI":"10.1021\/acsami.2c06503","volume":"14","author":"M Luo","year":"2022","unstructured":"Luo M, Yukawa H, Sato K, Tozawa M, Tokunaga M, Kameyama T, et al. Multifunctional magnetic CuS\/Gd(2)O(3) nanoparticles for fluorescence\/magnetic resonance bimodal imaging-guided photothermal-intensified chemodynamic synergetic therapy of targeted tumors. ACS Appl Mater Interfaces. 2022;14:34365\u201376.","journal-title":"ACS Appl Mater Interfaces"},{"key":"4243_CR179","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202302208","volume":"10","author":"J Huang","year":"2023","unstructured":"Huang J, Deng G, Wang S, Zhao T, Chen Q, Yang Y, et al. A NIR-II photoactivatable \u201cROS bomb\u201d with high-density Cu(2) O-supported MoS(2) nanoflowers for anticancer therapy. Adv Sci. 2023;10:e2302208.","journal-title":"Adv Sci"},{"key":"4243_CR180","doi-asserted-by":"publisher","first-page":"14954","DOI":"10.1021\/acsnano.5c00721","volume":"19","author":"X Liu","year":"2025","unstructured":"Liu X, Zhang H, Guan S, Tan J, Yeung KWK, Ouyang L, et al. Electron pump and photon trap effect-derived selective antitumor of Fe-Ppy@CaO(2)-modified polyetheretherketone for bone tumor therapy. ACS Nano. 2025;19:14954\u201371.","journal-title":"ACS Nano"},{"key":"4243_CR181","doi-asserted-by":"publisher","first-page":"10487","DOI":"10.1021\/acs.nanolett.5c01949","volume":"25","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Wang Y, Zhang X, Yue L, Yang L, Lai H, et al. Nanohydroxyapatite-stabilized pickering-emulsion-incorporated hydrogel prevents postoperative osteosarcoma recurrence and promotes bone repair. Nano Lett. 2025;25:10487\u201396.","journal-title":"Nano Lett"},{"key":"4243_CR182","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.jconrel.2024.06.009","volume":"372","author":"RP Shukla","year":"2024","unstructured":"Shukla RP, Tiwari P, Sardar A, Urandur S, Gautam S, Marwaha D, Tripathi AK, Rai N, Trivedi R, Mishra PR. Alendronate-functionalized porous nano-crystalsomes mitigate osteolysis and consequent inhibition of tumor growth in a tibia-induced metastasis model. J Control Release. 2024;372:331\u201346.","journal-title":"J Control Release"},{"key":"4243_CR183","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202204852","volume":"19","author":"D Zhang","year":"2023","unstructured":"Zhang D, Tan J, Xu R, Du H, Xie J, Peng F, et al. Collaborative design of MgO\/FeO(x) nanosheets on titanium: combining therapy with regeneration. Small. 2023;19:e2204852.","journal-title":"Small"},{"key":"4243_CR184","doi-asserted-by":"publisher","first-page":"150156","DOI":"10.1016\/j.bbrc.2024.150156","volume":"722","author":"Q Yuan","year":"2024","unstructured":"Yuan Q, Wu Y, Xue C, Zhao D, Wang H, Shen Y. KAT7 serves as an oncogenic gene and regulates CCL3 expression via STAT1 signaling in osteosarcoma. Biochem Biophys Res Commun. 2024;722:150156.","journal-title":"Biochem Biophys Res Commun"},{"key":"4243_CR185","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202303636","volume":"19","author":"C Xu","year":"2023","unstructured":"Xu C, Xia Y, Zhuang P, Liu W, Mu C, Liu Z, et al. FePSe(3) -nanosheets-integrated cryogenic-3D-printed multifunctional calcium phosphate scaffolds for synergistic therapy of osteosarcoma. Small. 2023;19:e2303636.","journal-title":"Small"},{"key":"4243_CR186","doi-asserted-by":"publisher","first-page":"3138","DOI":"10.1039\/D4TB02290D","volume":"13","author":"X Liu","year":"2025","unstructured":"Liu X, Zhang P, Xu M, Zhao Z, Yin X, Pu X, Wang J, Liao X, Huang Z, Cao S, Yin G. Mixed-valence vanadium-doped mesoporous bioactive glass for treatment of tumor-associated bone defects. J Mater Chem B. 2025;13:3138\u201360.","journal-title":"J Mater Chem B"},{"key":"4243_CR187","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.2147\/IJN.S356453","volume":"17","author":"M Si","year":"2022","unstructured":"Si M, Xia Y, Cong M, Wang D, Hou Y, Ma H. In situ co-delivery of doxorubicin and cisplatin by injectable thermosensitive hydrogels for enhanced osteosarcoma treatment. Int J Nanomed. 2022;17:1309\u201322.","journal-title":"Int J Nanomed"},{"key":"4243_CR188","doi-asserted-by":"publisher","DOI":"10.1007\/s10856-016-5699-0","volume":"27","author":"ZJ Rong","year":"2016","unstructured":"Rong ZJ, Yang LJ, Cai BT, Zhu LX, Cao YL, Wu GF, et al. Porous nano-hydroxyapatite\/collagen scaffold containing drug-loaded ADM-PLGA microspheres for bone cancer treatment. J Mater Sci Mater Med. 2016;27:89.","journal-title":"J Mater Sci Mater Med"},{"key":"4243_CR189","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-46003-6","volume":"15","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Li C, Guo A, Yang Y, Nie Y, Liao J, et al. Black phosphorus boosts wet-tissue adhesion of composite patches by enhancing water absorption and mechanical properties. Nat Commun. 2024;15:1618.","journal-title":"Nat Commun"},{"key":"4243_CR190","doi-asserted-by":"publisher","DOI":"10.1093\/rb\/rbaf033","volume":"12","author":"H Cheng","year":"2025","unstructured":"Cheng H, Chen J, Wang Y, Zhang Y, Qin T, Sun H, et al. Sr-doped surfaces with 2D black phosphorus nanosheets for enhanced photothermal antibacterial activity and zirconia implant osseointegration. Regen Biomater. 2025;12:rbaf033.","journal-title":"Regen Biomater"},{"key":"4243_CR191","doi-asserted-by":"publisher","DOI":"10.1002\/adma.201705611","author":"B Yang","year":"2018","unstructured":"Yang B, Yin J, Chen Y, Pan S, Yao H, Gao Y, et al. 2D-black-phosphorus-reinforced 3D-printed scaffolds: a stepwise countermeasure for osteosarcoma. Adv Mater. 2018;30:1705611. https:\/\/doi.org\/10.1002\/adma.201705611.","journal-title":"Adv Mater"},{"key":"4243_CR192","doi-asserted-by":"publisher","first-page":"2874","DOI":"10.1039\/C6TB00390G","volume":"4","author":"Y Zhang","year":"2016","unstructured":"Zhang Y, Zhai D, Xu M, Yao Q, Chang J, Wu C. 3D-printed bioceramic scaffolds with a Fe(3)O(4)\/graphene oxide nanocomposite interface for hyperthermia therapy of bone tumor cells. J Mater Chem B. 2016;4:2874\u201386.","journal-title":"J Mater Chem B"},{"key":"4243_CR193","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.201901031","volume":"8","author":"M Zhang","year":"2019","unstructured":"Zhang M, Zhang J, Chen J, Zeng Y, Zhu Z, Wan Y. Fabrication of Curcumin-Modified TiO(2) nanoarrays via cyclodextrin based polymer functional coatings for osteosarcoma therapy. Adv Healthc Mater. 2019;8:e1901031.","journal-title":"Adv Healthc Mater"},{"key":"4243_CR194","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2022.102455","volume":"298","author":"G Solinc","year":"2022","unstructured":"Solinc G, Svigelj T, Omersa N, Snoj T, Pirc K, Znidarsic N, et al. Pore-forming moss protein bryoporin is structurally and mechanistically related to actinoporins from evolutionarily distant cnidarians. J Biol Chem. 2022;298:102455.","journal-title":"J Biol Chem"},{"key":"4243_CR195","doi-asserted-by":"publisher","first-page":"e9298","DOI":"10.7717\/peerj.9298","volume":"8","author":"P Rattanaporn","year":"2020","unstructured":"Rattanaporn P, Tongsima S, Mandrup-Poulsen T, Svasti S, Tanyong D. Combination of ferric ammonium citrate with cytokines involved in apoptosis and insulin secretion of human pancreatic beta cells related to diabetes in thalassemia. PeerJ. 2020;8:e9298.","journal-title":"PeerJ"},{"key":"4243_CR196","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1039\/C6TB02865A","volume":"5","author":"H Cheng","year":"2017","unstructured":"Cheng H, Gong Z, Hu H, Zhang M, Liu X, Xu Y, Zeng Y, Chen J, Zhu Z. Design of alveolate Se-inserted TiO(2) and its effect on osteosarcoma cells and osteoblasts. J Mater Chem B. 2017;5:1988\u20132001.","journal-title":"J Mater Chem B"},{"key":"4243_CR197","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202105598","volume":"9","author":"L Zhang","year":"2022","unstructured":"Zhang L, Zhang M, Guo H, Tian Z, Ge L, He G, et al. A universal polyiodide regulation using quaternization engineering toward high value-added and ultra-stable zinc-iodine batteries. Adv Sci. 2022;9:e2105598.","journal-title":"Adv Sci"},{"key":"4243_CR198","doi-asserted-by":"publisher","first-page":"25480","DOI":"10.1039\/C8RA03943G","volume":"8","author":"JF Liu","year":"2018","unstructured":"Liu JF, Wei L, Duolikun D, Hou XD, Chen F, Liu JJ, Zheng LP. Preparation of porous calcium phosphate microspheres with phosphate-containing molecules at room temperature for drug delivery and osteogenic differentiation. RSC Adv. 2018;8:25480\u20138.","journal-title":"RSC Adv"},{"key":"4243_CR199","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2023.124406","volume":"240","author":"J Liu","year":"2023","unstructured":"Liu J, Lin S, Dang J, Wang S, Cheng W, Ran Z, et al. Anticancer and bone-enhanced nano-hydroxyapatite\/gelatin\/polylactic acid fibrous membrane with dual drug delivery and sequential release for osteosarcoma. Int J Biol Macromol. 2023;240:124406.","journal-title":"Int J Biol Macromol"},{"key":"4243_CR200","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202406639","volume":"21","author":"D Xie","year":"2025","unstructured":"Xie D, Hu C, Zhu Y, Yao J, Li J, Xia J, et al. Sequential therapy for osteosarcoma and bone regeneration via chemodynamic effect and cuproptosis using a 3D-printed scaffold with TME-responsive hydrogel. Small. 2025;21:e2406639.","journal-title":"Small"},{"key":"4243_CR201","doi-asserted-by":"publisher","first-page":"44065","DOI":"10.1021\/acsami.2c10772","volume":"14","author":"Y Ma","year":"2022","unstructured":"Ma Y, Jiang L, Hu J, Zhu E, Zhang N. Developing a versatile multiscale therapeutic platform for osteosarcoma synergistic photothermo-chemotherapy with effective osteogenicity and antibacterial capability. ACS Appl Mater Interfaces. 2022;14:44065\u201383.","journal-title":"ACS Appl Mater Interfaces"},{"key":"4243_CR202","volume":"18","author":"B Chen","year":"2023","unstructured":"Chen B, Mei L, Fan R, Chuan D, Ren Y, Mu M, et al. Polydopamine-coated i-motif DNA\/Gold nanoplatforms for synergistic photothermal-chemotherapy. Asian J Pharm Sci. 2023;18:100781.","journal-title":"Asian J Pharm Sci"},{"key":"4243_CR203","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1080\/15685551.2020.1804183","volume":"23","author":"T Wang","year":"2020","unstructured":"Wang T, Zhang F, Zhao R, Wang C, Hu K, Sun Y, et al. Polyvinyl alcohol\/sodium alginate hydrogels incorporated with silver nanoclusters via green tea extract for antibacterial applications. Des Monomers Polym. 2020;23:118\u201333.","journal-title":"Des Monomers Polym"},{"key":"4243_CR204","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2024.122675","volume":"311","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Zhang N, Xing J, Sun Y, Jin X, Shen C, et al. In situ hydrogel based on Cu-Fe(3)O(4) nanoclusters exploits oxidative stress and the ferroptosis\/cuproptosis pathway for chemodynamic therapy. Biomaterials. 2024;311:122675.","journal-title":"Biomaterials"},{"key":"4243_CR205","doi-asserted-by":"publisher","first-page":"5218","DOI":"10.1039\/D3BM00532A","volume":"11","author":"R Han","year":"2023","unstructured":"Han R, Min Y, Li G, Chen S, Xie M, Zhao Z. Supercritical CO(2)-assisted fabrication of CM-PDA\/SF\/nHA nanofibrous scaffolds for bone regeneration and chemo-photothermal therapy against osteosarcoma. Biomater Sci. 2023;11:5218\u201331.","journal-title":"Biomater Sci"},{"key":"4243_CR206","doi-asserted-by":"publisher","DOI":"10.1002\/adtp.201900102","author":"W Yang","year":"2020","unstructured":"Yang W, Veroniaina H, Qi X, Chen P, Li F, Ke PC. Soft and condensed nanoparticles and nanoformulations for cancer drug delivery and repurpose. Adv Ther. 2020;3:1900102. https:\/\/doi.org\/10.1002\/adtp.201900102.","journal-title":"Adv Ther"},{"key":"4243_CR207","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-75820-4","volume":"14","author":"M Naveed","year":"2024","unstructured":"Naveed M, Mahmood S, Aziz T, Azeem A, Rajpoot Z, Rehman SU, et al. Green-synthesis of silver nanoparticles AgNPs from Podocarpus macrophyllus for targeting GBM and LGG brain cancers via NOTCH2 gene interactions. Sci Rep. 2024;14:25489.","journal-title":"Sci Rep"},{"key":"4243_CR208","doi-asserted-by":"publisher","first-page":"9927","DOI":"10.1021\/acsnano.6b03835","volume":"10","author":"Y Wang","year":"2016","unstructured":"Wang Y, Wang J, Hao H, Cai M, Wang S, Ma J, et al. In vitro and in vivo mechanism of bone tumor inhibition by selenium-doped bone mineral nanoparticles. ACS Nano. 2016;10:9927\u201337.","journal-title":"ACS Nano"},{"key":"4243_CR209","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202501293","volume":"21","author":"SA Haris","year":"2025","unstructured":"Haris SA, Adhami S, Yuksel R, Kim SO. Bio-inspired zinc anodes: mitigating dendrite formation and side reactions in aqueous zinc metal batteries using laser carbonized chitosan layer. Small. 2025;21:e2501293.","journal-title":"Small"},{"key":"4243_CR210","doi-asserted-by":"publisher","DOI":"10.3390\/metabo12100958","author":"C Zhang","year":"2022","unstructured":"Zhang C, Xu T, Lin L, Shaukat A, Tong X, Yue K, et al. Morinda officinalis polysaccharides ameliorates bone growth by attenuating oxidative stress and regulating the gut microbiota in thiram-induced tibial dyschondroplasia chickens. Metabolites. 2022. https:\/\/doi.org\/10.3390\/metabo12100958.","journal-title":"Metabolites"},{"key":"4243_CR211","doi-asserted-by":"publisher","first-page":"1801233","DOI":"10.1002\/advs.201801233","volume":"6","author":"J Xu","year":"2019","unstructured":"Xu J, Wang H, Hu Y, Zhang YS, Wen L, Yin F, Wang Z, Zhang Y, Li S, Miao Y, et al. Inhibition of CaMKIIalpha Activity Enhances Antitumor Effect of Fullerene C60 Nanocrystals by Suppression of Autophagic Degradation. Adv Sci (Weinh). 2019;6:1801233.","journal-title":"Adv Sci (Weinh)"},{"key":"4243_CR212","doi-asserted-by":"publisher","first-page":"4426","DOI":"10.1039\/D0BM00898B","volume":"8","author":"R Wang","year":"2020","unstructured":"Wang R, Liu W, Wang Q, Li G, Wan B, Sun Y, Niu X, Chen D, Tian W. Anti-osteosarcoma effect of hydroxyapatite nanoparticles both in vitro and in vivo by downregulating the FAK\/PI3K\/Akt signaling pathway. Biomater Sci. 2020;8:4426\u201337.","journal-title":"Biomater Sci"},{"key":"4243_CR213","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.actbio.2020.04.009","volume":"109","author":"X Huang","year":"2020","unstructured":"Huang X, Chen J, Wu W, Yang W, Zhong B, Qing X, Shao Z. Delivery of MutT homolog 1 inhibitor by functionalized graphene oxide nanoparticles for enhanced chemo-photodynamic therapy triggers cell death in osteosarcoma. Acta Biomater. 2020;109:229\u201343.","journal-title":"Acta Biomater"},{"key":"4243_CR214","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2022.112507","volume":"216","author":"X Yin","year":"2022","unstructured":"Yin X, Ran S, Cheng H, Zhang M, Sun W, Wan Y, et al. Polydopamine-modified ZIF-8 nanoparticles as a drug carrier for combined chemo-photothermal osteosarcoma therapy. Colloids Surf B Biointerfaces. 2022;216:112507.","journal-title":"Colloids Surf B Biointerfaces"},{"key":"4243_CR215","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s00280-023-04554-3","volume":"92","author":"M Nagard","year":"2023","unstructured":"Nagard M, Ah-See ML, Strauss J, Wise-Draper T, Safran HP, Nadeau L, Edenfield WJ, Lewis LD, Ottesen LH, Li Y, Mugundu GM. Phase I study to assess the effect of adavosertib (AZD1775) on the pharmacokinetics of substrates of CYP1A2, CYP2C19, and CYP3A in patients with advanced solid tumors. Cancer Chemother Pharmacol. 2023;92:193\u2013203.","journal-title":"Cancer Chemother Pharmacol"},{"key":"4243_CR216","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21197220","author":"RC Popescu","year":"2020","unstructured":"Popescu RC, Straticiuc M, Mustaciosu C, Temelie M, Trusca R, Vasile BS, et al. Enhanced internalization of nanoparticles following ionizing radiation leads to mitotic catastrophe in MG-63 human osteosarcoma cells. Int J Mol Sci. 2020;21:7220. https:\/\/doi.org\/10.3390\/ijms21197220.","journal-title":"Int J Mol Sci"},{"key":"4243_CR217","doi-asserted-by":"publisher","first-page":"7401","DOI":"10.1039\/D1TB01084K","volume":"9","author":"YC Wang","year":"2021","unstructured":"Wang YC, Dai HL, Li ZH, Meng ZY, Xiao Y, Zhao Z. Mesoporous polydopamine-coated hydroxyapatite nano-composites for ROS-triggered nitric oxide-enhanced photothermal therapy of osteosarcoma. J Mater Chem B. 2021;9:7401\u20138.","journal-title":"J Mater Chem B"},{"key":"4243_CR218","doi-asserted-by":"publisher","DOI":"10.3389\/fchem.2022.1045612","volume":"10","author":"H Ying","year":"2022","unstructured":"Ying H, Wang H, Jiang G, Tang H, Li L, Zhang J. Injectable agarose hydrogels and doxorubicin-encapsulated iron-gallic acid nanoparticles for chemodynamic-photothermal synergistic therapy against osteosarcoma. Front Chem. 2022;10:1045612.","journal-title":"Front Chem"},{"key":"4243_CR219","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtbio.2025.101796","volume":"32","author":"X Tan","year":"2025","unstructured":"Tan X, Wang Y, Yuan Y, Song Y, Xia J, Yi X, et al. A catalase-powered self-oxygen-generating soft nanomotor for photodynamic therapy of osteosarcoma. Mater Today Bio. 2025;32:101796.","journal-title":"Mater Today Bio"},{"key":"4243_CR220","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-024-02419-2","volume":"22","author":"M Li","year":"2024","unstructured":"Li M, Wang M, Huang J, Tang S, Yang J, Xu Z, et al. High-performance pyrite nano-catalyst driven photothermal\/chemodynamic synergistic therapy for Osteosarcoma. J Nanobiotechnology. 2024;22:141.","journal-title":"J Nanobiotechnology"},{"key":"4243_CR221","doi-asserted-by":"publisher","DOI":"10.3390\/polym15183659","author":"H Chen","year":"2023","unstructured":"Chen H, Hu Y, Wu C, Liu K, Feng R, Yang M, et al. Mesoporous titanium dioxide nanoparticles-poly(N-isopropylacrylamide) hydrogel prepared by electron beam irradiation inhibits the proliferation and migration of oral squamous cell carcinoma cells. Polymers. 2023;15:3659. https:\/\/doi.org\/10.3390\/polym15183659.","journal-title":"Polymers"},{"key":"4243_CR222","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1002\/EXP.20210003","volume":"1","author":"J Liu","year":"2021","unstructured":"Liu J, Chen C, Wei T, Gayet O, Loncle C, Borge L, et al. Dendrimeric nanosystem consistently circumvents heterogeneous drug response and resistance in pancreatic cancer. Exploration (Beijing). 2021;1:21\u201334.","journal-title":"Exploration (Beijing)"},{"key":"4243_CR223","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1021\/acsnano.9b04571","volume":"14","author":"J Vanderburgh","year":"2020","unstructured":"Vanderburgh J, Hill JL, Gupta MK, Kwakwa KA, Wang SK, Moyer K, et al. Tuning ligand density to optimize pharmacokinetics of targeted nanoparticles for dual protection against tumor-induced bone destruction. ACS Nano. 2020;14:311\u201327.","journal-title":"ACS Nano"},{"key":"4243_CR224","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202301759","volume":"10","author":"G Zhang","year":"2023","unstructured":"Zhang G, Zhan M, Zhang C, Wang Z, Sun H, Tao Y, et al. Redox-responsive dendrimer nanogels enable ultrasound-enhanced chemoimmunotherapy of pancreatic cancer via endoplasmic reticulum stress amplification and macrophage polarization. Adv Sci. 2023;10:e2301759.","journal-title":"Adv Sci"},{"key":"4243_CR225","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s11671-024-04011-x","volume":"19","author":"MA Farooqi","year":"2024","unstructured":"Farooqi MA, Farooqi HMU, Bhatti T, Siddiqui GU, Kausar F, Kang CU. Functionalization of niobium nitrogen-doped titanium dioxide (TiO(2)) nanoparticles with ethanolic extracts of Mentha arvensis. Discov Nano. 2024;19:67.","journal-title":"Discov Nano"},{"key":"4243_CR226","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202200938","volume":"11","author":"L Zhou","year":"2022","unstructured":"Zhou L, Liang H, Ge Y, Ding W, Chen Q, Zhang T, et al. Precisely targeted nano-controller of PD-L1 level for non-small cell lung cancer spinal metastasis immunotherapy. Adv Healthc Mater. 2022;11:e2200938.","journal-title":"Adv Healthc Mater"},{"key":"4243_CR227","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202201451","volume":"9","author":"B Wang","year":"2022","unstructured":"Wang B, Bai J, Tian B, Chen H, Yang Q, Chen Y, et al. Genetically engineered hematopoietic stem cells deliver TGF-beta inhibitor to enhance bone metastases immunotherapy. Adv Sci (Weinh). 2022;9:e2201451.","journal-title":"Adv Sci (Weinh)"},{"key":"4243_CR228","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1021\/acs.accounts.9b00079","volume":"52","author":"Z Chen","year":"2019","unstructured":"Chen Z, Wang Z, Gu Z. Bioinspired and biomimetic nanomedicines. Acc Chem Res. 2019;52:1255\u201364.","journal-title":"Acc Chem Res"},{"key":"4243_CR229","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.01861-24","volume":"99","author":"S Kumari","year":"2025","unstructured":"Kumari S, Biswas A, Maiti TK, Bandyopadhyay B, Banerjee A. Induction of PD-1 and CD44 in CD4(+) T cells by circulatory extracellular vesicles from severe dengue patients drives endothelial damage via the NF-kB signaling pathway. J Virol. 2025;99:e0186124.","journal-title":"J Virol"},{"key":"4243_CR230","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1158\/1535-7163.MCT-22-0570","volume":"22","author":"Y Nagira","year":"2023","unstructured":"Nagira Y, Nagira M, Nagai R, Nogami W, Hirata M, Ueyama A, et al. S-531011, a novel anti-human CCR8 antibody, induces potent antitumor responses through depletion of tumor-infiltrating CCR8-expressing regulatory T cells. Mol Cancer Ther. 2023;22:1063\u201372.","journal-title":"Mol Cancer Ther"},{"key":"4243_CR231","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2023.1065773","volume":"11","author":"J Zhan","year":"2023","unstructured":"Zhan J, Zhang M, Zhou L, He C. Combination of immune checkpoint blockade and targeted gene regulation of angiogenesis for facilitating antitumor immunotherapy. Front Bioeng Biotechnol. 2023;11:1065773.","journal-title":"Front Bioeng Biotechnol"},{"key":"4243_CR232","doi-asserted-by":"publisher","first-page":"6247","DOI":"10.1021\/acsnano.2c09685","volume":"17","author":"Y Wang","year":"2023","unstructured":"Wang Y, Wu Y, Li L, Ma C, Zhang S, Lin S, et al. Chemotherapy-sensitized in situ vaccination for malignant osteosarcoma enabled by bioinspired calcium phosphonate nanoagents. ACS Nano. 2023;17:6247\u201360.","journal-title":"ACS Nano"},{"key":"4243_CR233","first-page":"73","volume":"25","author":"J Ge","year":"2023","unstructured":"Ge J, Yang N, Yang Y, Yu H, Yang X, Wang Y, et al. The combination of eddy thermal effect of biodegradable magnesium with immune checkpoint blockade shows enhanced efficacy against osteosarcoma. Bioact Mater. 2023;25:73\u201385.","journal-title":"Bioact Mater"},{"key":"4243_CR234","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-023-02129-1","volume":"21","author":"W Chen","year":"2023","unstructured":"Chen W, Li Z, Yu N, Zhang L, Li H, Chen Y, et al. Bone-targeting exosome nanoparticles activate Keap1 \/ Nrf2 \/ GPX4 signaling pathway to induce ferroptosis in osteosarcoma cells. J Nanobiotechnology. 2023;21:355.","journal-title":"J Nanobiotechnology"},{"key":"4243_CR235","doi-asserted-by":"publisher","first-page":"11923","DOI":"10.2147\/IJN.S480586","volume":"19","author":"Q Song","year":"2024","unstructured":"Song Q, Zhang Y, Hu H, Yang X, Xing X, Wu J, et al. Augment of ferroptosis with photothermal enhanced Fenton reaction and glutathione inhibition for tumor synergistic nano-catalytic therapy. Int J Nanomed. 2024;19:11923\u201340.","journal-title":"Int J Nanomed"},{"key":"4243_CR236","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202302272","volume":"10","author":"X Yang","year":"2023","unstructured":"Yang X, Gao S, Yang B, Yang Z, Lou F, Huang P, et al. Bioinspired tumor-targeting and biomarker-activatable cell-material interfacing system enhances osteosarcoma treatment via biomineralization. Adv Sci (Weinh). 2023;10:e2302272.","journal-title":"Adv Sci (Weinh)"},{"key":"4243_CR237","doi-asserted-by":"publisher","first-page":"7699","DOI":"10.1021\/acs.nanolett.3c02414","volume":"23","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Zhang Q, Wang F, Li M, Shi X, Li J. Activatable semiconducting polymer nanoinducers amplify oxidative damage via sono-ferroptosis for synergistic therapy of bone metastasis. Nano Lett. 2023;23:7699\u2013708.","journal-title":"Nano Lett"},{"key":"4243_CR238","doi-asserted-by":"publisher","first-page":"e24833","DOI":"10.1016\/j.heliyon.2024.e24833","volume":"10","author":"Z Jamshidi","year":"2024","unstructured":"Jamshidi Z, Dehghan R, Nejabat M, Abnous K, Taghdisi SM, Hadizadeh F. Dual-targeting CD44 and mucin by hyaluronic acid and 5TR1 aptamer for epirubicin delivery into cancer cells: synthesis, characterization, in vitro and in vivo evaluation. Heliyon. 2024;10:e24833.","journal-title":"Heliyon"},{"key":"4243_CR239","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics11070945","author":"F Pedrini","year":"2022","unstructured":"Pedrini F, Nazato VS, Hausen MA, Komatsu D, Pena SS, Almeida ALM, et al. In vitro cell behavior and antibiotic activity under sustained release of doxycycline-loaded poly(lactic-co-glycolic acid) microspheres. Antibiotics (Basel). 2022;11:945. https:\/\/doi.org\/10.3390\/antibiotics11070945.","journal-title":"Antibiotics (Basel)"},{"key":"4243_CR240","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics17010061","author":"M Jaskolski","year":"2025","unstructured":"Jaskolski M, Paczkowska-Walendowska M, Miklaszewski A, Cielecka-Piontek J. Ashwagandha: optimizing the extraction and electrospun nanofiber production. Pharmaceutics. 2025;17:61. https:\/\/doi.org\/10.3390\/pharmaceutics17010061.","journal-title":"Pharmaceutics"},{"key":"4243_CR241","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.909880","volume":"13","author":"R Lopes","year":"2022","unstructured":"Lopes R, Caetano J, Barahona F, Pestana C, Ferreira BV, Lourenco D, et al. Multiple myeloma-derived extracellular vesicles modulate the bone marrow immune microenvironment. Front Immunol. 2022;13:909880.","journal-title":"Front Immunol"},{"key":"4243_CR242","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1021\/acs.inorgchem.2c03203","volume":"62","author":"G Quinones Velez","year":"2023","unstructured":"Quinones Velez G, Paris Santiago A, Soto Nieves D, Figueroa Guzman A, Peterson-Peguero E, Lopez-Mejias V. Functionalization of titanium dioxide by in situ surface crystallization of bisphosphonate-based coordination complexes. Inorg Chem. 2023;62:201\u201312.","journal-title":"Inorg Chem"},{"key":"4243_CR243","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1039\/C7NR07035G","volume":"10","author":"TDT Nguyen","year":"2017","unstructured":"Nguyen TDT, Pitchaimani A, Ferrel C, Thakkar R, Aryal S. Nano-confinement-driven enhanced magnetic relaxivity of SPIONs for targeted tumor bioimaging. Nanoscale. 2017;10:284\u201394.","journal-title":"Nanoscale"},{"key":"4243_CR244","doi-asserted-by":"publisher","first-page":"9440","DOI":"10.1021\/acs.inorgchem.3c00542","volume":"62","author":"L Carmona-Sarabia","year":"2023","unstructured":"Carmona-Sarabia L, Quinones Velez G, Escalera-Joy AM, Mojica-Vazquez D, Esteves-Vega S, Peterson-Peguero EA, et al. Design of extended bisphosphonate-based coordination polymers as bone-targeted drug delivery systems for breast cancer-induced osteolytic metastasis and other bone therapies. Inorg Chem. 2023;62:9440\u201353.","journal-title":"Inorg Chem"},{"key":"4243_CR245","doi-asserted-by":"publisher","first-page":"8365","DOI":"10.1021\/acsomega.1c00092","volume":"6","author":"J Gao","year":"2021","unstructured":"Gao J, Huang J, Shi R, Wei J, Lei X, Dou Y, et al. Loading and releasing behavior of selenium and doxorubicin hydrochloride in hydroxyapatite with different morphologies. ACS Omega. 2021;6:8365\u201375.","journal-title":"ACS Omega"},{"key":"4243_CR246","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1158\/1078-0432.CCR-18-1521","volume":"25","author":"DLJ Thorek","year":"2019","unstructured":"Thorek DLJ, Ku AT, Mitsiades N, Veach D, Watson PA, Metha D, et al. Harnessing androgen receptor pathway activation for targeted alpha particle radioimmunotherapy of breast cancer. Clin Cancer Res. 2019;25:881\u201391.","journal-title":"Clin Cancer Res"},{"key":"4243_CR247","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adx6350","volume":"11","author":"AJ Canning","year":"2025","unstructured":"Canning AJ, Vu T, Menozzi L, Klippel P, Chen X, Chen J, et al. Advancing precision photothermal therapy by integrating armored gold nanostars with real-time photoacoustic thermometry and imaging. Sci Adv. 2025;11:eadx6350.","journal-title":"Sci Adv"},{"key":"4243_CR248","doi-asserted-by":"publisher","DOI":"10.3390\/jfb15080232","author":"Y Liu","year":"2024","unstructured":"Liu Y, Corbascio T, Huang J, Engellau J, Lidgren L, Tagil M, et al. Surgery combined with local implantation of doxorubicin-functionalized hydroxyapatite halts tumor growth and prevents bone destruction in an aggressive osteosarcoma. J Funct Biomater. 2024;15:232.  https:\/\/doi.org\/10.3390\/jfb15080232.","journal-title":"J Funct Biomater"},{"key":"4243_CR249","doi-asserted-by":"publisher","first-page":"3116","DOI":"10.1039\/D0BM00003E","volume":"8","author":"J Qu","year":"2020","unstructured":"Qu J, Teng D, Sui G, Guan S, Wang Y, Wang Q, Lin Y, Ran H, Wang Z, Wang H. A photothermal-hypoxia sequentially activatable phase-change nanoagent for mitochondria-targeting tumor synergistic therapy. Biomater Sci. 2020;8:3116\u201329.","journal-title":"Biomater Sci"},{"key":"4243_CR250","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202411188","volume":"21","author":"S Luo","year":"2025","unstructured":"Luo S, Zhao C, Wang R, Chang Z, Di J, Wang Y, et al. Higher tumor\/organ accumulation ratio of porous dual infinite coordination polymer nanocomposites for efficient tumor photothermal-starvation-dual hypoxia chemo synergistic therapy. Small. 2025;21:e2411188.","journal-title":"Small"},{"key":"4243_CR251","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-021-01088-9","volume":"19","author":"H Chen","year":"2021","unstructured":"Chen H, Deng J, Yao X, He Y, Li H, Jian Z, et al. Bone-targeted erythrocyte-cancer hybrid membrane-camouflaged nanoparticles for enhancing photothermal and hypoxia-activated chemotherapy of bone invasion by OSCC. J Nanobiotechnology. 2021;19:342.","journal-title":"J Nanobiotechnology"},{"key":"4243_CR252","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2024.105503","volume":"111","author":"H Hu","year":"2025","unstructured":"Hu H, Li X, Xu Z, Tao Y, Zhao L, You H, et al. OPG promotes lung metastasis by reducing CXCL10 production of monocyte-derived macrophages and decreasing NK cell recruitment. EBioMedicine. 2025;111:105503.","journal-title":"EBioMedicine"},{"key":"4243_CR253","doi-asserted-by":"publisher","DOI":"10.1002\/btm2.10472","volume":"8","author":"SY Yoo","year":"2023","unstructured":"Yoo SY, Mun YH, Kang NW, Koo JM, Lee DH, Yoo JH, et al. Enhancement of the therapeutic efficacy of the MAP regimen using thiamine pyrophosphate-decorated albumin nanoclusters in osteosarcoma treatment. Bioeng Transl Med. 2023;8:e10472.","journal-title":"Bioeng Transl Med"},{"key":"4243_CR254","doi-asserted-by":"publisher","first-page":"2781","DOI":"10.1021\/acs.molpharmaceut.3c01186","volume":"21","author":"MG Fuster","year":"2024","unstructured":"Fuster MG, Wang J, Fandino O, Villora G, Paredes AJ. Folic acid-decorated nanocrystals as highly loaded trojan horses to target cancer cells. Mol Pharm. 2024;21:2781\u201394.","journal-title":"Mol Pharm"},{"key":"4243_CR255","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.jconrel.2021.12.039","volume":"342","author":"NW Kang","year":"2022","unstructured":"Kang NW, Lee JY, Kim DD. Hydroxyapatite-binding albumin nanoclusters for enhancing bone tumor chemotherapy. J Control Release. 2022;342:111\u201321.","journal-title":"J Control Release"},{"key":"4243_CR256","doi-asserted-by":"publisher","first-page":"4349","DOI":"10.7150\/thno.43402","volume":"10","author":"F Xu","year":"2020","unstructured":"Xu F, Zhu J, Lin L, Zhang C, Sun W, Fan Y, et al. Multifunctional PVCL nanogels with redox-responsiveness enable enhanced MR imaging and ultrasound-promoted tumor chemotherapy. Theranostics. 2020;10:4349\u201358.","journal-title":"Theranostics"},{"key":"4243_CR257","doi-asserted-by":"publisher","DOI":"10.1080\/10717544.2023.2181743","volume":"30","author":"Q Ju","year":"2023","unstructured":"Ju Q, Huang R, Hu R, Fan J, Zhang D, Ding J, et al. Phytic acid-modified manganese dioxide nanoparticles oligomer for magnetic resonance imaging and targeting therapy of osteosarcoma. Drug Deliv. 2023;30:2181743.","journal-title":"Drug Deliv"},{"key":"4243_CR258","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.972212","volume":"13","author":"H Zhu","year":"2022","unstructured":"Zhu H, Mao F, Wang K, Feng J, Cheng S. Cuproptosis-related lncRNAs predict the clinical outcome and immune characteristics of hepatocellular carcinoma. Front Genet. 2022;13:972212.","journal-title":"Front Genet"},{"key":"4243_CR259","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-025-03882-z","volume":"25","author":"W Xu","year":"2025","unstructured":"Xu W, Chen XC, Wang Y, Chen JC, Cao ZJ, Huang R, et al. Palmitoylation regulators drive the progression of clear cell renal cell carcinoma through inhibition of cuproptosis: insights into the role of ZDHHC18. Cancer Cell Int. 2025;25:230.","journal-title":"Cancer Cell Int"},{"key":"4243_CR260","doi-asserted-by":"publisher","first-page":"21134","DOI":"10.1021\/acsnano.3c04903","volume":"17","author":"J Xia","year":"2023","unstructured":"Xia J, Hu C, Ji Y, Wang M, Jin Y, Ye L, et al. Copper-loaded nanoheterojunction enables superb orthotopic osteosarcoma therapy via oxidative stress and cell cuproptosis. ACS Nano. 2023;17:21134\u201352.","journal-title":"ACS Nano"},{"key":"4243_CR261","doi-asserted-by":"publisher","DOI":"10.1016\/j.nano.2023.102669","volume":"50","author":"D Li","year":"2023","unstructured":"Li D, Ma S, Xu D, Meng X, Lei N, Liu C, et al. Peptide-functionalized therapeutic nanoplatform for treatment orthotopic triple negative breast cancer and bone metastasis. Nanomedicine. 2023;50:102669.","journal-title":"Nanomedicine"},{"key":"4243_CR262","doi-asserted-by":"crossref","unstructured":"Piszczek P, Radtke A, Ehlert M, Jedrzejewski T, Sznarkowska A, Sadowska B, Bartmanski M, Erdogan YK, Ercan B, Jedrzejczyk W. Comprehensive Evaluation of the Biological Properties of Surface-Modified Titanium Alloy Implants. J Clin Med 2020;9:342.","DOI":"10.3390\/jcm9020342"},{"key":"4243_CR263","doi-asserted-by":"publisher","DOI":"10.3390\/ma12213583","author":"M Doubkova","year":"2019","unstructured":"Doubkova M, Nemcakova I, Jirka I, Brezina V, Bacakova L. Silicalite-1 layers as a biocompatible nano- and micro-structured coating: an in vitro study on MG-63 cells. Materials. 2019;12:3583. https:\/\/doi.org\/10.3390\/ma12213583.","journal-title":"Materials"},{"key":"4243_CR264","doi-asserted-by":"publisher","first-page":"2711","DOI":"10.1039\/D2BM02004A","volume":"11","author":"J Zhu","year":"2023","unstructured":"Zhu J, Han Q, Li Q, Wang F, Dong M, Liu N, Li X, Chen D, Yang D, Song Y, Yang Y. A multi-enzyme-like activity exhibiting mussel-inspired nanozyme hydrogel for bacteria-infected wound healing. Biomater Sci. 2023;11:2711\u201325.","journal-title":"Biomater Sci"},{"key":"4243_CR265","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202400715","volume":"13","author":"W Wang","year":"2024","unstructured":"Wang W, Kang W, Zhang X, Zheng X, Jin Y, Ma Z, et al. Microenvironment-responsive targeted nanomedicine for a collaborative integration of tumor theranostics and bone defect repair. Adv Healthc Mater. 2024;13:e2400715.","journal-title":"Adv Healthc Mater"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-026-04243-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04243-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04243-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T11:04:23Z","timestamp":1776251063000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12951-026-04243-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,7]]},"references-count":265,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4243"],"URL":"https:\/\/doi.org\/10.1186\/s12951-026-04243-2","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,7]]},"assertion":[{"value":"31 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"356"}}